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ABSTRACT 
Thi s study was carried out in 2 parts: 
1. Genome analysis of human adenovirus species 7; 
2. Search for a possi b 1 e vi ra 1 aeti o 1 ogy in oesophagea 1 ca rei noma. 
Sixteen 1 aboratory i so 1 ates of adenovi rus species 7, i so 1 a ted in South 
Africa between 1975 and 1986, were characterized by restriction endo-
nuclease analysis of their DNA genomes. Virus was propagated in human 
embryo fi brob 1 ast ce 11 s; genomi c DNA, extracted and purified from 
cellular DNA extracts, was analyzed using 9 different restriction 
enzymes. Results of this study have demonstrated 2 new genome types of 
adenovirus 7c which have not previously been identified. 
ii 
The 2 novel strains, designated as genome types Ad7c1 and Ad7c2, were 
shown to differ from prototype Ad7 c according to restri cti on profi 1 es 
with EcoRI; 2 new EcoRI sites were demonstrated in Ad7c1 and 1 in Ad7c2. 
The restriction sites were mapped on the viral genomes (at 3.68kb and 
5.32kb from the left ternrinus) by double enzyme digestions, cloning of 
viral DNA, and nucleic acid hybridization using a cloned Ad7 probe. 
Strains resembling the prototype Ad7c and Ad7p (Gomen) genome types 
were also identified in the 1985 and 1986 Ad7 isolates. 
In order to investigate the possible role of a viral co-factor in the 
aetiology of oesophageal carcinoma, 18 probes, derived from potentially 
oncogenic vi ruses, were used to screen 3 hwnan oesophageal carcinoma 
cell lines for the possible presence of integrated viral DNA. One of 
these, an Ad7 recombinant plasmid probe, was developed by cloning DNA 
from the transfornri ng region of the Ad7cl strain into the plasmid 
vector pUC19. 
\ 
Cellular DNA, extracted from the 3 ttanOr lines HCU18, HCU33 and HCU39, 
was tested by means of both DNA dot hybridization and Southern blot 
hybridization for the presence of Epstein-Barr virus, h~,m~an papilloma-
virus (types 1, 5, 6, 8, 11, 16, 18), human adenovirus (strains 5, 7, 
12, 31) and human T -1 ymphotropi c vi rus type I DNA. Both assays were 
demonstrated to be sensitive enough to detect 1 copy of vi ra 1 DNA per 
iii 
ce 11. No hybri di zati on between HPV, EBV, HTLV- I or adenovi rus DNA probes, 
and the cellular DNA was detected. These findings indicate that the 
stable integration of these tumor vi ruses in host chromosomes did not · 
play a role in the maintenance of the malignant phenotype of the 3 
extensively pa~saged cell lines. 
Cells of the 3 oesophageal tumor lines were further examined by trans-
mi ssi on e 1 ectron mi croscopy, but the presence of vi rus parti c 1 es in 
these cells was not observed. 
Parts of this thesis have been accepted for publication: 
1. South African Medical Journal (Supplement), 71(6), 6-8, 1987. 
2~ Journal of Medical Virology, 1987 (in press). 
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PART I 
TWO NEW GENOME TYPES OF HUMAN ADENOVIRUS SPECIES 7 
1 
1. INTRODUCTION 
The human adenoviruses, initially discovered by Rowe and col-
Leagues in 195Y (Rowe et al., 1953) are medium-sized viruses, 
containing Linear double-stranded DNA genomes, 33-45 kilobase 
pairs Ckb) in Length. In 1962 it was discovered that certain 
species (formerly serotypes; Wigand et al., 1982) are oncogenic. 
when injected into newborn hamsters <Huebner et al., 1967>. Since 
then, these viruses have been used extensively as a model for 
studies on tumor 
vitro. 
induction in vivo and ceLL· transformation in 
1.1 CLASSIFICATION OF ADENOVIRUSES 
Up to now 41 human adenovirus species have been recognized. These 
are divided into 7 subgenera <Table'1). Huebner <1967) originally 
classified the human adenoviruses into 3 subgenera on the basis ot 
their oncogenicity in newborn hamsters. Subgenus A is highly 
oncogenic, inducing tumors with high frequency and after a short 
Latency period; subgenus B is weakly oncogenic, causing tumors in 
a fraction of the injected animals after long Latency periods; and 
subgenus C is nononcogenic. Subgenus C was Later further sub~ 
divided into subgenera c, D and E on the basis of differences in 
the antigenicity of the T antigen, and GC content of the genome 
(McALLister et al., 1969; Wadell et al., 1980). ALL members of 
subgenera A-E are also capable of morphologically transforming rat 
or hamster cells in vitro. <The difference between the in vivo and 
in vitro properties is tho~ght to be due to the different im-
munological responses elicited by the various subgenera). In 
addition, Wadell et al. <1980) have analyzed the internal polypep-
tides of the 41 human adenovirus species, and extended the number 
of subgenera to a total of 7. Through genome analysis, they have 
also shown that the number of Smai restriction fragments of the 
adenovirus genomes was characteristic for each subgenus, and, with 
an exception for subgenus A Cdue to heterogeneity of their 
genomes) different species belonging to the same subgenus dis-
played several comigrating restriction fragments. 
The antigenic determinants that define the human adenovirus 
species, localized on the viral hexons and fibers, are measured by 
neutralization and hemagglutination-inhibition tests, 
/. 
/ 2 
respectively. Hexon and fiber antigens are coded for by only a 
minor fraction of the viral genome. Therefore these traditional 
serological techniques cannot accurately be used for studying 
relationships between different viruses, since the information 
derived would be representative of a few gene products only. This 
point is itLustrated by the fact that Ad12, Ad18 and Ad31 cross-
react serologically <Hierholzer et al., 1975; Wigand and Keller, 
· 1978), while their viral genomes only exhibit 48-69~ DNA homology 
<Green et al., 1979). Furthermore·, within the group of human 
adenoviruses, a wide genetic variation is expressed, and serologi-
cal intermediates are frequently encountered <Wadell et al., 
1980). 
TABLE 1 Properties of Human Adenovirus Subgenera A to G 
Sub-
genus 
A 
B 
c 
D 
E 
F 
G 
Species 
12,18,31 
3,7,11,14 
16*21 ,34 
35 
1 I 2. 5 I 6 
8,9,10,13,15 
17, 19 1 20 
22 - 30 
32, 33 
36 - 39 
4 
40 
41 
a : Percent homology 
with members of 
b: n. d. , not done 
DNA 
Homologya G+C 
(~) (%) 
48-69 48 
(8-20) 
89-94 51 
<9-20) 
99-100 58 
(10-16) 
94-99 58 
<4-17) 
( 4-·23) 58 
n.d. b n. d .. 
n. d. n.d. 
Hemagglu- Oncogenicity 
tination in Newborn 
Patterns Hamsters 
Nr.of 
Smai 
Fragments 
4-5 
8-10 
10-12 
14-18 
16-19 
9 
11-12 
IV High 
I Weak 
I I I Nil 
I I N i l 
I I I Nil 
IV Nil 
IV N i l 
within subgenus. Figures i n brackets: homology 
other subgenera. 
Adapted from data cited by Wadell <1984). 
<Subdivision according to polypeptide patterns, not shown). 
3 
1.1.1 The Importance of Genome Analysis 
The · recent advent of restriction endonuclease analysis of 
adenovirus strains has proved a sensitive technique for the clas-
sification of these viruses, and is second only to nu~leotide 
sequence analysis. 
The original 
confirmed by 
distiriction of the accept~d subgenera, has now been 
restriction endonuclease analysis <Wadell et al., 
1980) and furthermore,species distinctions within subgenera, based 
on neutralization tests,ha~e also been reinforced. However, dif-
ferences among strains of the same species cannot be detected by 
the traditional serological techniques <namely, hemagglutination 
inhibition or neutralization tests). In this regard DNA restric-
tion analysis provides a powerfu( tool whereby distinct viral 
entities, designated genome types <or genotypes>, can be defined. 
Different genome types within a species have been associated with 
different degrees of virulence and pathogenicity, and have also 
been found to vary in prevalence in human populations at different 
times <Wadell et al., 1981). Thus analysis of genome types is ~f 
clinical and epidemiological importance. It has further uses in: 
1. the study of relationships between viruses at 
the genome level; 
2. characterization of noncultivable viruses, and 
3. tracing infection chains. 
1 .1.2 Classification of Adenovirus Species 7 Genome Types 
Adenovirus type 7 <Ad?) is the adenovirus species that has been 
most frequently associated with severe disease. Li and Wadell 
<1986> have recently published an analysis of 40 selected strains 
of Ad7 from around the world, using 12 different restriction 
endonucleases. They have identified 15 different genome types, 
designated Ad7p, Ad7p1, Ad7a, Ad7a1 to Ad7a5, Ad7b, Ad7c, Ad7d, 
Ad7d1, Ad7e, Ad7f and Ad7g. This adds eight new types to the seven 
which had previously been identified by using restriction en-
donucleases BamHI and Smai, namely Ad7p <Berge et al., 1955), the 
4' 
prototype strain Gomen of Ad?, Ad7a CRowe et al., 1958>, the 
vaccine strain, Ad?b, Ad?c, Ad?d, Ad?e, and Ad?f <Wadell et al., 
1981; Wadell et al., 1985; Wadell and Varsanyi, 1978; Wadell et 
al., 1980>. They found that only four restriction endonucleases, 
8 am H I , 8 c l I , .fifll..I and X b a I need t o b e u s e d t o d i s t i n g u i s h a ll 1 5 
Ad? genome types. 
Sa it ey and 
this group, 
type 
Richmond 
namely 
Ad?b 
(1986) 
A d?b 1 I 
have since added a further three to 
Ad7b2 and Ad7b3. These variants of 
\ 
genome 
isolated during an 
were identified after analysis of 44 strains 
epidemic in England at the end of 1983. The 
variants occurred at approximately similar frequencies throughout 
the epidemic and were associated with similar clinical illnesses. 
In essence, this classification of Ad7 is based on designating the 
prototype strain as p and variants on 8amHI digestion patterns, 
where restriction fragment Length polymorphism is limited to less 
than 3% of the fragment, being designated as a group with an 
alphabetic letter as a name <a, b, c, etc.>. Through the use of 
the computer program "COMAP", initially described by Adrian and 
Heinrich (1986>, which facilitates the pairwise analyses of co-
migrating DNA restriction fragments, restriction fragment Length 
polymorphism variants can be identified. Variants within in-
dividual groups - distinguished by use of additional restriction 
endonucleases, are designated by arabic numerals (1, 2, 3, etc.>, 
in the order in which they are discovered. 
1.2 EPIDEMIOLOGY OF ADENOVIRUS SPECIES 7 INFECTIONS 
Restriction endonuclease analysis has proved to be invaluable in 
studies of the molecular epidemiology of adenoviruses. Wadell et 
al. <1985) have recently analyzed the distribution of the dif-
ferent Ad7 genome type~ among 314 isolates from patient~ and 
healthy shedders from around the world. The majority of isolates 
(90%) were represent.ed by the Ad7b and Ad7c genome types, and 
these appeared to be mutually exclusive. In Europe Ad7c was 
prevalent from 1958 to 1969, while Ad7b has been prevalent since 
1969. A similar shift from Ad7c to Ad7b occurred in Australia, but 
t h i s was not d.e t e c t e d u n t i l 1 9 7 5 . Ad 7 b genome types have 
predominated in Australia, Europe and North America during the 
last decade, but the reason for this shift from Ad7c to Ad7b as 
causative agents in Ad7 respiratory outbreaks remains unknown. 
Among 22 Ad7 strains isolated in Johann~sburg (South Africa) 
during the period of 1961 and 1976, one isolated in April 1967 wa~ 
~enome typed as Ad7b, while the rest were identified as Ad7c. 
Thus Africa~ and Brazil and Japan <where Ad7e and Ad7p were 
d~tected, respectively) represent the only regions where Ad7b has 
not been detected in recent years. 
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1.3 PATHOGENICITY OF ADENOVIRUS SPECIES 7 INFECTIONS 
Adenoviruses have been reported to be the causative agents in 
approximately 2% of all acute res pi rat or Y' infections in non-
hospitalised children, and in 4%-25% of infections in chiLdren 
hospitalised with such symptoms <van der Veen, 1963). Although 
Ad7 is also known to produce mild upper respiratory or gastroin-
testinal illness, it is, in most cases, associated with epidemic 
outbreaks of Lower respiratory tract disease and relatively high 
m o r t at i t y ( S t r au be e t a L . , 1 9 8 3 > . Genome t y p e s 7 b and 7 c appear t o 
be responsible for the most severe cases of Ad7 related disease, 
and for the community outbreaks that have been reported. 
Although there have be~n few examples of nosocomial ou~breaks, 
Straube et al. (1983> have described such an epidemic that oc-
curred in a San Diego childrens' hospital in September 1980 
causing the death of 4 out of 6 patients infected with adenovirus 
type 7b , and have demonstrated that infections with Ad7 can cause 
serious and potentially fatal disease in hospitalised patients and 
staff, even 
community. 
during times of minimal Ad7 activity (n the Larger 
Fee et al. <1983> who reported a similar outbreak in a I . 
Pennsylvania paediatric hospital, have suggested that more effec-
tive infection-control measures should be taken in order to 
prevent such infections. 
The fact that supervening viral pneumonia - caused by adenovirus 
or herpesvirus infections - can follow in the wake of measle&, is 
also well recognized. This is especially important in South Africa 
where measles is known to be an important cause of morbidity and 
mortality among poor chiLdren. Kaschula et al. <1983>, who carried 
out a study of this phenomenon in the Red Cross Childrens' 
H6spital, Cape ~own, have emphasised the importance of these 
supervening secondary infections as contributing factors to such 
morbidity and mortality. 
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1.4 AIM OF THIS WORK 
In May 1986 a small outbreak of pneumonia occurred in a 
respiratory intensive care ward of the Red Cross Childrens' War 
Memorial Hospital, Cape Town. Virus was isolated from respiratori 
secretions from 4 children in our routine diagnostic virology 
Laboratories and all were typed as adenovirus species 7 by routine 
serological techniques. Two of the 4 children had post measles 
pneumonia while the others had underlying respiratory problems, 
and appeared to acquire the adenovirus pneumonia in hospital. Two 
of the 4 children died: one with post measles pneumonia, and one 
other. 
Tbe purpose of this study was to type the viral isolates by 
restric~ion endonuclease analysis, and then to compare them both 
to other recent isolates of Ad? f~om the Local community, and to a 
similar group isolated in the Johannesburg area. A third aim was 
to develop a recombinant Ad? probe, using DNA from the transform-
ing region of one of the strains. This pro~e was then used as part 
of a survey which screened DNA from three human oesophageal car-
cinoma cell Lines for the possible presence of integrated DNA 
tumor viruses <Part II of thesis). 
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2. MATERIALS AND METHODS 
2.1 ORIGIN OF REFERENCE STRAINS AND PATIENT ISOLATES 
Reference strains of adenovirus 7 were obtained as follows: Ad7a 
from National Institute of Health <NIH), Bethesda, USA; Ad7p, 
Ad7b, Ad7c, from Dr. G. Wadell, University of Umea, Sweden. 
Strains 2314, 2332, 2256, 2203 and 2182 were all patient isolates 
obtained in our routine diagnostic virology laboratories. The 
first four represent a group isolated in May 1986, from 
respiratory secretions of 4 children in a small outbreak of 
pneumonia in a respiratory intensive care ward of the Red Cross 
Childrens' War Memorial Hospital, Cape Town. Strain 2182 is a 
single lung isolate, initially isolated in 1975, and stored at 
0 
-20 C, from a young child who died of post measles pneumonia <from 
the same hospital). The 1985/1986 group of 11 isolates- Nrs. 
2154, 2168, 2156, 2153, 1980, 1727, 2084, 274, 548, 702, and 1004 
were obtained from Dr. A. Kidd at the National Institute of 
Virology CNIV) in Johannesburg. 
2.2 INITIAL IDENTIFICATION OF VIRUS STRAINS 
A detailed descr·iption of tissue culture media and methods used is 
given in Appendix I and II, respectively. All viral isolates were 
typed by standard methods, fn our routine diagnostic virology 
Laboratories, prior to restriction endonuclease analysis: 
Specimens were inoculated o~to confluent monolayers of HeLa cells 
grown on 8 x 22 mm 2 glass coverslips,. which were held in airtight, 
sterile, roller tubes <~imax), and grown under rotation in a 37°c 
incubator. The virus was allowed to grow for 1-2 days Cat 37°C) 
after which the coverslips were removed, and stained with 
haematoxylin and eosin, according to standard procedure <Humason, 
1972>, such that a typical adenoviral cytopathic effect CCPE) 
co~(d be observed. Species identification, as an adenovirus type-
7, was routinely accomplished by neutralization with hyperimmune 
serum <NIH). Human embryo fibroblasts, derived from lung or whole 
embryo explant cultures in our Laboratory, and grown in sterile 
plastic tubes <Falcon) under rotation at 37°C, were similarly 
infected with viral isolates and observed for signs of a typical 
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adenoviral CPE. When extensive cytopathic change was evident the 
growth medium of certain of these cultures was removed, and stored 
at -20°C, to serve as a stock of infectious virus for subsequent 
viral propagation and DNA extraction. 
2.3 VIRUS PROPAGATION AND DNA EXTRACTION 
Viral isolates, and reference strains, were propagated in 
monolayers of human embryo fibroblast CHF> cells. Harvests of 5-
o 10ml of infected cell medium (stored at -20 C) were thawed and 
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used to inoculate semi-confluent HF cell sheets grown in 75 em 
tissue culture flasks <Appendix II). After removal of the growth 
medium, the stock virus suspension was added and spread evenly 
over the 
incubated 
surface of the cell culture. The culture flask was then 
. 0 . (in a horizontal position) for 1 hour at 37 C, to 
facilitate adsorption of the virus to the cells. Following this 
time period, the cell culture medium was made up to 50ml by the 
addition of 40-45ml of growth medium - Eagle's minimum essential 
medium, supplemented with 10% foetal calf serum (Appendix I>. The 
0 . 
cells were maintained in a standard co 2 incubator at 37 C, and 
observed daily for evidence of typical cytopathic changes. When 
more than 75% of cells showed the characteristic CPE, usually 
within 4-6 days, DNA was extracted by a modification of the wHirt" 
procedure <Eizuru et al., 1984). 
After removal of the medium the cells w~re washed twice with 
phosphate buffered saline <pH 7.0), and then lysed gently for 20 
mins at 37°C, with a Lysing solution <4ml per flask) consisting of 
0.01M Tris (pH 8.0), 0.6% SDS. and 0.01M EDTA <pH8.0). Sodium 
chloride was added to a final concentration of 1M, and the mixture 
was kept at 4°C overnight to facilitate p~ecipitation of high 
molecular weight cellular DNA. The "Hirt supernatantw <containing 
predominantly viral DNA) was then separated by centrifugation at 
10 000 rpm for 60 mins <Sorval~ RC-5 centrifuge) at 4°C. It was 
subsequently 
500~~/ml for 
equilibrated 
digested with proteinase K <Boehringer Mannheim> at 
1 hour at 56°C, and then extracted twice with Tris-
phenol,and once with chloroform <chloroform 
isoamylalcohol, 24:1). The aqueous and organic phases were 
separated, after each extraction, by centrifugation at 3 000 rpm 
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for 10 mins. Viral DNA was precipitated with 2.5 volumes of ab-
solute ethanol and '300mM sodium acetate <NaAc> at -20°C overnight 
<or alternatively at -70°C for 10 mins), and pelleted · at 10000 
rpm 
of 
2 Ot-•.g 
for 6 0 m i n s . The pre c i p i t ate d DNA was t hen d i s sol v e d i n 50 0 t-.tl 
RNase buffer <0.1M NaCl, 0.01M Tris,'pH8.0) and treated with 
of RNase A (Sigma) by incubation .at 37°C for 60 mins. The 
RNase had been pre-heated to remove any DNase activity <Maniatis 
et al., 1982~ pg 451). The digestion was terminated by extractioh 
once with phenol, and once' with chloroform, and viral DNA again 
preci~itated by the addition of 2.5 volumes of absolute ~thanol 
and 300mM NaAc, at -20°C overnight. After centrifugation at 12 000 
rpm for 15 mins, the viral DNA pellet was washed with cold 70% 
ethan o l , vacuum d r i e d, and red i s solved i n 1 0 0 t-.tl of s t e r i l e d i s-
tilled water. It could then be stored at 4°C until used for 
restriction endonuclease analysis. 
2.4 RESTRICTION ENDONUCLEASE ANALYSIS 
The concentrations of extracted viral DNA were determined by 
c om p a r i s on w i t h k n ow n c on c e n t r a t i o n s o f ?-.. - p h a g e D N A f o l l ow i n g 
agarose gel electrophoresis and ethidium bromide staining of the 
DNA: Electrophoresis was carried out in 1% agarose gels in TAE 
buffer (40mM acetate, 2mM EDTA, 40mM Tris, pH 7.6) at 80V for 
approximately 30 mins. The gels were stained with 500~g/ml 
ethidium bromide and photographed with ultra violet transillumina-
tion C300nm) using a Mamiya ~amera and Polaroid Land pack 667 
film. The intensity of the UV light i~duced fluorescence of the 
viral DNA was compared with that of the ·;'·.DNA standards. 
Restriction endonuclease digestion was carried out according to 
the directions of the manufacturers <Amersham or Boehringer 
Mannheim> Aliquots containing 2~~ of viral DNA in a total volu~e 
of 20~l were digested with 2 to 4 units of different restriction 
endonucleases <RE) and 2~l of the appropriate enzyme buffer. All 
reactions were carried out for 2 hours at 37°C. To identify the 
location of new RE recognition sites, double RE digests, with the 
enzymes Sall and EcoRI, were carried out in selec•ted cases. In 
such instances the high salt buffer, specified by the manufacturer 
for .use with EcoRI, was utilised and the reactions carried out in· 
parallel. D i g e s t i on s were term i nate d by t he add i t i on of 2t-.tl of 
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STOP buffer <SO% v/v glycerol, 100mM EDTA, 1% w/v SDS, 0.1% 
w/v bromophenol blue, 0.1% w/v xylene cyanol) and subsequent 
heating at 65°C for 10 mins. The mixtures were then applied to 
horizontal 1.0% agarose gels, and the fragments separated by 
electrophoresis in TAE buffer at a constant voltage of 2V/cm for 
16-18 hours. After staining the gels in a solution of 500~~/ml 
ethidium bromide in TAE buffer, for 15-30 mins, the bands could be 
visualized by UV transillumination. Patterns were recorded on 
Ilford FP4 photographic film. 
In certein cases restriction enzyme profiles of Ad7 strains were 
transferred, after separation in 1% agarose gels, onto Hybond-N 
nylon membranes <Amersham) by using a modification of the method 
described by Southern <1975>. In this event a ruler was ~Laced 
next to the molecular weight <mw> markers, before photographing 
the gel. 
plotted 
The reciprocal of the mobility of the mw markers was 
against their known fragment sizes <in kilobases). This 
enabled the sizes of specific viral DNA fragments to be read from 
the graph after autoradiography <Southern, 1975). 
Viral DNA was denatured and neutralized in situ prior to transfer: 
Initially the gel was washed twice for 5 mins in 0.25M HCL, to 
depurinate the DNA at random. The DNA was then denatured in 0.5M 
NaOH and 1M NaCL; the gel was washed twice in 300ml of the 
denaturing buffer for 20 mins each, rinsed in distilled water, and 
neutralized by two washes in 0.5M Tris (pH 7. 5) and 3M NaC l. 
2.5 TRANSFER OF DNA TO NYLON MEMBRANES 
A sheet of Hybond-N nylon membrane <Amersham) was cut to the exact 
size of the gel. Two sheets of Whatman 3MM filter paper were also 
cut to the same size, and two additional sheets cut to ap-
proximately 40cm x 40cm. The two large filters were saturated in 
20X s~c <3M NaCL, 0.3M tri-sodium citrate, pH7.4) and placed on a 
piece of Saran wrap on a flat bench surface. Care was taken at all 
stages to prevent the trapping of bubbles between the different 
Layers of gel, membrane and filter paper. If any were trapped they 
were removed by rolling a glass rod over the membrane/filters to 
force the bubble out. The pre-treated gel was then slid onto the 
centre of the filters and air-bubbles removed. The uncovered 
12 
filter paper was covered with Saran wrap in order to ensure 
diffu-
sion of the 20X sse through the gel and to preven
t buffer 
evaporation during the transfer. It is not necessary to 
pre-soak 
the Hybond-N nylon membrane as i t is hydrophilic and wets 
directly 
on contact with the gel. After lowering i t carefully 
onto the 
surface of the gel, it was covered with th~ two filters
 of the 
same size, the first of which had been pre-soaked in 20X 
sse. A 
stack of tissues were folded to the exact size of the ge
l, and 
placed 
placed 
on top of the filter papers. A glass plate and ~eight were 
on top of these ~~d transfer was then allowed to proceed 
for 16-24 hours at room temperature. Saturated tissues we
re re-
placed with dry ones when necessary. 
After transfer of the.DNA, the positions of the wells in 
the gel 
were marked on the overlying nylon membrane. The membrane wa
s then 
removed, rinsed in 1X sse, and air-dried. The DNA was fixe
d onto 
the membrane by placing it, DNA-side downwards, .on an ultra
violet 
transilluminator and exposing it to UV-illumination <300n
m) for 
15-20 mins. In this way DNA becomes covalently linked t
o the 
Hybond-N nylon membrane surface. 
2.6 CLONING OF ADENOVIRUS SPECIES 7 EcoRI D FRAGMENT 
2.6.1 Digestion of vector and viral DNA 
One microgram of DNA from Adehovirus species 7 <strain 220
3> and 
from the plasmid vector, pUC19, was digested with EcoRI acc
ording 
to standard procedures. An aliquot <one tenth volume) of each 
reaction volume was run on a 1% agarose minigel in order to
 check 
that the digestion had been complete. Reactions were termina
ted by 
a phenol, and subsequent chloroform extraction. The DNA wa
s then 
precipitated with 2 volumes of ice-cold absolute ethanol 
in the 
presence of 300mM NaAc. After centrifugation <at 12 000 rpm 
for 10 
mins) the resultant DNA pellets were washed with 70% ethanol and 
d r i e d under · vacuum . V e c tor and v i r a l DNA were re-d i s solved i
 n 2 0 t-.tl' 
and 10Ml, respectively, of sterile distilled water. 
samples were then stored on ice prior to ligation. 
The two 
1.4 
2.6.4 Bacterial transformation and selection of recombinants 
Competent E.coli JM107 cells were prepared by calcium chloride 
pretreatment <Maniatis et.al.,1982; pg 250). Cells were stored 
·o (resuspended in SOmM cacl 2 and 10mM Tris, pH 8.0) at 4 C for 12-24 
hours prior to transformation. 
L i gat i on m i x e s < 1 0 t..Ll "> we r e added to 2 0 0 ~-tl a l i quo t s o f p r e t r eat e.d 
JM107 cells, mixed, and stored on ice for 30 mins. A 20ng aliquot 
of undigested pUC19 DNA ~as similarly added to 200~l of.E.coli 
JM107 cells, to serve as a transformation control. The mixtures 
were then heated at 42°C for 2 mins, after which 1ml of Luria 
broth <LB medium; Maniatis et al., 1982, pg.68> was added to each 
a~d incubation continued at 37°C for 1 hour. The transformed JM107 
cells were plated on Luria agar plates <Maniatis et al., 1982; 
pg.70> containing SOt-'-l of X-:;-GAL (2% w_/v 5-bromo-4-chloro-3-
indolyl-t?.-galactoside, in dimethylformamide>, 20t..tl of 1PTG (100mM 
Isopropropyl-e-D-thio-galactopyranoside, in distilled water> a~d 
SO~.r.g/ml ampicillin per 20ml agar. Plates were incubated at 37°C 
for 16 hours. Blue colonies on control plates were then counted; 
0-3 colonies on the CIP control, and 200-250 colonies on the 
ligation control, indicated efficient dephosphorylation and liga-
tion reactions. The transformation efficiency was calculated from 
the number 
.efficiency 
of colonies on the transformation control; an average 
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of 0.6 x 10 transformants per ~g of DNA was achieved 
in this, an~ subsequent transformation reactions <refer to part 
II, Section 2.3.1>. White colonies, containing potential recom-
binant plasmids, were selected from experimental plates. Intact 
pUC19 plasmid encodes an 1PTG inducible e-galactosida•e enzyme 
which cleaves· X-GAL to give a blue reaction product. However, if 
the e-galactosidase gene is mutated by inserted DNA, no enzyme is 
produced and thus colonies containing recombinant plasmids are 
white. Potential recombinants were screened by inoculation of 10ml 
of LB medium containing SOt-~/ml ampicillin per millilitre:. These 
cultures were incubated·overnight at 37°C in a rotary incubator~ 
Plasmid DNA was then extracted by a rapid "miniprep" method 
<Birnboium and Doly, 1979>, and analyzed by restriction enzyme 
digestion, and subsequent electrophoresis in 1% agarose. 
2.7 LONGTERK STORAGE OF SELECTED RECOMBINANT 
PLASMID IN 15~ GLYCEROL 
After selecting the required Ad7 recombinant plasmid a glycerol 
stock of the transformed JM107 cells was made for long-term 
storage at -70°C. An 850~~ volume of E.coli JM107 cells, taken 
from a 10ml overnight culture, was mixed with 150~l of sterile 
glycerol, rapidly frozen on dry ice, and then stored at -70°c. 
Viable bacteria could be recovered by further inoculation of 10~~ 
of the thawed suspension into 10ml of LB medium, containing 
50~~/ml ampicillin. 
2.8 PLASMID PREPARATION AND RADIOISOTOPE 
LABELLING OF VIRAL DNA INSERT 
2.8.1 Amplification and isolation of plasmid DNA 
E.coli JM107 carrying the required Ad7 recombinant plasmid was 
inoculated from the stock culture into 10ml LB medium, containing 
0 50 ~·.glml ampicillin. After overnight growth, at 37 C, 100~L of 
this starter culture was inoculated into 25ml of LB medium con-
taining ampicillin <50~~/ml). Growth at 37°C was allowed to 
proceed, with constant rotation, until the oo 600 of the medium was 
between 0.6 and 1.0 units. At this stage the bacterial cells were 
in the Late logarithmic phase of growth. This late log culture 
C25ml) was then inoculated into 500ml of LB medium, containing 
ampicillin <SO t-.~/mU, and incubation at 37°C continued for a 
further 2.5 hours. At this point chloramphenicol <Sigma) was added 
to a final concentration of 170~~/ml. and the subsequent 
amplification allowed to proceed, with vigorous shaking, for 12-16 
hours. 
The bacterial cells were harvested by centrifugation at 
6 000 rpm for 10 mins at 4°C, washed in 100 ml of ice-cold STE 
<0.1M NaCL, 10mM Tris [pH7.8J, 1 mM EDTA), and then lysed accord-
ing to the "alkaline Lysis procedure" described by Maniatis et al. 
<1982; pg.90-91). This method is highly efficient for the isola-
tion of small plasmids, Less than 10 kilobases in Length. 
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After dissolving the final DNA pellet in 8ml of TE buffer (pH8.0> 
plasmid DNA was further purified from contaminating chromosomal 
DNA by centrifugation to equilibrium in ces.ium chloride <CsCl>, 
ethidium bromide density gradients. Cesium chloride <Boehringer I ' , 
Mannheim) at a concentration of 1g/ml, was added to the DNA solu-
tion, dissolved, and then 0.8ml of a solution of eth}dium bromide 
<10mg/ml in H20> added for .every
 10ml of CsCl solution. The final 
'density of the solution should be 1.55g/ml <refractive indexi 
1.386). The refractive index of the solution was determined by 
using a refractometer <SCIEX), and adjusted to a reading of 1.386-
1.390 by the addition of solid CsCl. The CsCl solution was then 
centrifuged at 50 000 rpm, for 20 hours, in a Beckman 
ultracentrifuge at 20°C <v Ti 65 rotor). The lower plasmid band 
was collected, and extracted 3-4 times with isoamylalcohol <Merck> 
in order to remove the ethidJum bromide. The aqueous phase was 
dialyzed for 20-24 hours, at 4°C against four changes of TE 
<pH8.0). After one phenol extraction and a subsequent extraction 
with chloroform, plasmid DNA was precipitated by the addition of 2 
volumes of absolute ethanol in the presence of 300mM NaAc. The 
precipitate was recovered by centrifugation, at 12 000 rpm for 10 
mins, washed in a small volume of 70Y. ethanol and dried under 
vacuum. The DNA was redissolved tn 0.2-0.4ml TE buffer (pH8.0>, 
and the final DNA concentration was calculated by determining· the 
absorbance at 260 nm: DNA concentration = <oD 260 x 50 x 
dilution)Mg/ml. 
2.8.2 Isolation of viral DNA from the 
recombinant bacterial plasmid 
The cloned viral DNA insert was excised from the recombinant 
bacterial plasmid prior to radioisotope .Labelling, so as to avoid 
any spurious hybridization of vector DNA sequences. The method 
used was a modification of that described by Dretzen et al. 
(1981). 
The recombinant plasmi? was digested with EcoRI, and the viral DNA 
insert was separated from the vector DNA by agarose gel 
electrophoresis <in 0.8Y. agarose in TAE buffer [pH8.0J). To iso-
late the viral DNA, DEAE-cellulose paper <Whatman>, presoaked in 
' . 
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electrophoresis buffer, was placed in· a slit ih the gel im-
mediately in front of the DNA band. Electrophoresis was then 
continued at 100V for 10-15 mins until the viral DNA had migrated 
onto the DE A E paper . As the g e l con t a i ned e t h i d i u m b.r om i de 
<1~~/ml> the migration of the DNA band could be monitored inter-
mittently by UV illumination <300nm>. DEAE paper was then removed, 
cut into a fine pulp with a razor blade and suspended in 300~l of 
elution buffer <20mM Tris [pH7.5J, 1mM EDTA, 1.5 M NaCl). After 
incUbation for tw~ hou~s at 37°C, th~ sample was mixed on a vortex 
mixer and centrifuged at 12 000 rpm for 10 mins. The supernatant 
w a s co ll e c t e d and t he paper p e ll e t w a s m i x e d w i t h a fur t her 2 0 0 P-l 
of elution buffer. This suspension was centrifuged <12 000 rpm for 
10 mins> ·and the resultant supernatant pooled with the former to 
-
make up the final volume of SOO~l. 
After extraction with an equal v~lume of phenol, and sUbsequent 
chloroform extrac~ion, 
of absolute ethanol and 
was then pelleted 
the DNA was precipitated with two volumes 
300mM NaAc at -20°C overnight. Insert DNA 
by centrifugation <12 000 rpm for 10 
mins>,washed with ?Or. ethanol, dried under vacuum and redissolved 
in 10 ~l of TE buffer <pH8.0>. The concentration of the purified 
viral DNA insert was determined by comparison with known con-
centrations of ~ DNA following agarose gel electrophoresis and 
ethidium bromide staining of the DNA, as described in Section 2.4. 
2.8.3 Radioisotope labelling of the ex.cised viral DNA insert 
Radioisotope labelling of viral DNA was carried out according to 
standard procedures, as specified by the manufacturer (Amersham) 
of the "Nick-Translation Kit" which was used. Insert DNA 
<0.5-1 ~g) was incubated for 90 mins at 15°C in the presence of 
1 0 0 P-C i . 0.3 2 P- d C T P , o f spec i f i c a c t i v i t y 4 0 0 C i I m m o l < Am e r s h am > , and 
20 ~~/l dATP, dGTP and dTTP in a concentrated nick translation 
buffer solution. To this solution 5 units of DNA polymerase I and 
100pg DNase I was added, and the final reaction volume made up to 
100~-ll with sterile distilled water. The nick-translation reaction 
. 
was terminated by loading the mixture directly onto a 4cm x 1cm 
column of sephadex G-50 suspended in a buffer containing 150mM 
NaCl, 10mM EDTA, 0.1r. SDS and SOmM TrisCpH7.5). A 10~l volume of 
10X STOP buffer was added to the sample prior to loading in order 
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to monitor the progress of the sample through the column. Once ~he 
dye front had reached the halfway mark, sixteen three-drop frac-
tions were collected. Fractions containing radiolabelled DNA were 
detected with a Geiger-counter <mini-monitor type 5.10), and 
pooled. The radioactivity in a one hundredth volume aliquot of the 
pooled fractions was used for the accurate quantitation of the 
radioactivity by Cerenkov counting,· and the· specific activity (in 
d p m I 1-.tg ) o f t h e l a b e l l e d - D N A c a l c u l a t e d . s p e c i f i c a c t i v i t i e s o f 
8 (0.5 1> x 10 dpm/1-.tg were obtained. The radiolabelled DNA was 
denatured by heating to 100°C for 5 mins, followed by rapid cool-
ing on ice, in order to prevent re-annealing of the DNA strands. 
2.9 HYBRIDIZATION OF 32 P-LABELLED PROBE TO DNA BOUND 
TO HYBOND-~ NYLON MEMBRANES 
Hybridization was carried out according to the procedure of 
Johnson .:e..::t_--..::a::..:l:..:. - < 1984). The Hybond-N nylon membranes were 
prehybridized with a 10ml solution containing 0.25~ -w/v nonfat dry 
milk in 900mM NaCl, 90mM Na citrate <O.OSX BLOTTO, 6x SSC) at 
42°C for 4 hours. Radiolabelled, single-stranded probe DNA was 
the~ added to a further 10ml volume containing 0.05X BLOTTO, 6X 
sse and 50% formamide. Membranes were transferred to this solution 
and hybridization was allowed to continue for 16-18 hours, at/ 
42°e. Both the prehybridization and the hybridization reactions 
were carried out in plastic bags which were heat-sealed; care was 
taken to ensure that all air-bubbles had been removed. Membranes 
were then washed to remove any unbound and non-specifically bound 
probe. 
BLOTTO, 
Initial washes were twice, for 30 mins each, in O.OSX 
2X 
stringency 
sse and 0.1% SDS, at room temperature. Two final high 
washes were at 55°C in 0.1X sse and 0.1% SDS <also for 
30 mins each). Filters were then air-dried, covered with Saran 
wrap, and exposed to x-ray film <Kodak X-Omat MA) with intensify-
ing screens. Autoradiography was allowed to proceed for 16-24 
hours, at -70°e, prior to photographic development. 
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3 RESULTS 
3. 1 VIRUS PROPAGATION AND NUCLEIC ACID EXTRACTION 
3. 1 . 1 Initial Identification of Laboratory Isolates of Ad7 
ALL Ad7 virus 
neutralization 
Laboratories, 
isolates studied were routinely typed by standard 
tests 
or in 
<either in our 
the Laboratory 
routine diagnostic virology 
from which they were sent) 
prior to 
classified 
restriction endonuclease analysis. While these results 
them as adenovirus species 7 <subgenus 8) isolates, 
precise i.nformation on their specific genome types remained 
unknown. 
The Ad7 isolates were also shown to exhibit a typical adenovirus 
cytopathic effect when grown in monolayers of HeLa cells, or of 
human embryo fibroblast cells. This was observed after 1-2 days of 
0 growth at 37 C: HeLa cells, stained with haematoxylin and eosin 
(HCl.E), showed inclusions typical of adenovirus <Figure 1). 
FIGURE 1 
Cytopathic effect of 
adenovirus in HeLa cells. 
The typical basophilic 
intranuclear inclusions 
are displayed in cells 
showing vario~s stages -of 
infection. Uninfected 
cells are indicated. 
Magnification : 240X. 
Stain: HC{E. 
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3.1.2 DNA Extraction 
Virus was grown in human embryo fibrob~ast cells in sterile 75cm 2 
tissue culture flasks, and was extracted when 75X of the cells 
exhibited a typical CPE - usually after 5-6 days. Optimum nucleic 
acid yields were achieved when semi-confluent, as opposed to 
confluent, cell sheets were inoculated with virus. At this stage 
the cells are presumably more permeable, and easily accessible to 
the virus than when they are densely packed in a confluent ceLL' 
sheet. An average yield of 50 ~~ of viral DNA•per 75cm 2 tissue 
culture flask was achieved, and this figure was 1.5 to 2 fold 
higher than that obtained when confluent cell sheets were 
infected. 
3.2 RESTRICTION ENDONUCLEASE ANALYSIS 
3 .. 2.1 Introduction 
Li and Wadell (1986) -have shown that 'the restriction enzyme BamHI 
c an d i s t i n g u i s h t h e 1 0 m a j o r genom_ e t y p e s o f Ad 7 t h a t h a v e s o f a r 
been identified (i.e. Ad7p, Ad7p1, Ad7a, Ad7a1, Ad7b, Ad7c, Ad7d, 
Ad7e, Ad7f, Ad7g). Five of the 8 additional subtypes <Ad7d1, 
Ad7a2-5) can be distinguished with the enzymes Xbai, Bel! and 
~I. Three further subtypes of Ad7b CAd7b1, Ad7b2, Ad7b3), 
recently identified by Bailey and Richmond <1986), can be distin-
guished by digestion with Pvuii, ~I and Sstii. 
In order to determine the genome types of 4 viral isolates <2314, 
2203, 2256, 2332>, from 4 chi~dren in a small outbreak of 
pneumonia at the Red Cross Childrens' Hospital <Cape Town>, 
restriction enzyme profiles of the 4 isolates were com-
to one another, using 9 different enzymes, and 
those of 4 Ad7 reference strains (Ad7p, Ad7a, Ad7b, 
pared, firstly 
secondly to 
Ad7c) using the enzymes BamHI, Smai and EcoRI. These 3 enzymes 
by Wadell et al. (1981) in the initial identification were used 
and discrimination of the 4 above reference strains. One further 
Local ·1975 Ad7 isolate was similarly typed by genome analysis, for 
comparative purposes. 
3.2.2 Analysis of "1986 May" Ad7 Isolates 
(2314, 2203, 2256, 2332) 
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DNA extracted from the 4 Ad? isolates, 2314, 2203, 2256 and 2332, 
designated "1986 May" isolat~s. was analyzed with nine different 
restriction enzymes, namely BamHI, Smai, EcoRI, Xbai, !:!..12 .. ~._1; 
Hind I I I , .!!9l..I , !!gJ_I I and SaL I .. Resultant prof U e s for the f i r s t 3 
of these enzymes are shown in Figures 2A,B ahd C respectively. 
Reference strain Ad7a DNA was similarly digested, and ru~ as a 
control in lane 5 of each gel. All 4 "1986 May" isolates were 
found to give identical patterns when digested with each of these 
9 restriction enzymes. Thus it would appear that the outbreak of 
respiratory infection, associated with these isolates, was caused 
by 1 particular virulent strain of adenovirus species 7. In addi-
tion, by comparison with pubCished Ad7 re~triction maps ·(Li, 
1986), patterns de~ived with each of these restriction enzymes, 
excluding EcoRI, appeared identical to those reported for Ad7c. 
3.2.3 Analysis of Ad7 Reference Strains, and One 1975 Isola~~ 
~ In order to determine the particular Ad7 genome type represented 
by the "1986 May" isolates, DNA from reference.strains Ad7p, Ad7a, 
Ad7b and Ad7c was digested with BamHI, Smai and EcoRI, and their 
resultant rest.riction enzyme profiles, as shownin F1gure 3 A, B 
and C, respectively, compared w~th those of the "1986 May" iso-
Lates <Lane 6 of Figure 3A, Band c>. Wadell et al. <1981) have 
described the use of these 3 enzymes in the initial identification 
of Ad7c. This genome type can be distinguished from the other 3 
above reference strains by cleavage either with BamHI, or with 
EcoRI and Smai. Patterns obtained with EcoRI are identical for 
Ad7c and Ad7b, and those obtained with Smal identical for Ad7a and 
Ad7c. 
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FIGURE 2 
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A 
B 
c 
D 
E 
F 
G 
H 
DNA restriction patterns after digestion of DNA from adenovirus 
"1986 May" isolates with (A) BamHI, (8) Smai and (C) EcoRI. Two 
micrograms of DNA from each of the following isolates, were 
digested and separated as described in the text: 
Lane 1 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Ad7 - 2314 
Ad7 - 2203 
Ad7 - 2256 
Ad? - 2332 
Adenovirus 7a reference strain 
RE fragments are indicated 
A 
B 
c 
8 c A 
1234567 123456 7 12345 67 
FIGURE 3 
DNA restriction patterns after digestion of DNA from adenovirus 
reference strains, and laboratory isolates, with (A) BamHI, (8) 
Smal and <C) EcoRI : 
Lane 1 Lambda ( ~) phage DNA cleaved with Hindiii, as molecular 
weight reference. 
Lane 2 Ad7p 
Lane 3 Ad7a 
Lane 4 Ad7b 
Lane 5 Ad7c 
Lane 6 Ad7-2203 <1986, May) 
Lane 7 Ad7-2182 <1975) 
Cellular <HF) bands are indicated in 
< ~ Hindiii restriction fragments 
size: 23.13; 9.42; 6.68; 4.36; 2.32; 
Figure 3C. 
<kb), in order of descending 
2 . 03; 0.56) 
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One 1975 adenovirus species 7 isolate- Nr.2182- was similarly 
analyzed, and is represented in Lane 7 of each gel. This specimen 
was originally isolated from ~ patient in the sam~ ward at the Red 
Cross Hospital as the "1986 May" group,.and was included for 
comparative purposes, since a similar 1975 isolate, from this 
ward, was typed in 1983 by Dr. G. Wadell (University of Ume~. 
Sweden) as an Ad?c genotype <Wadell et al., 1983>. 
The patterns derived for all Ad? reference strains tested CAd?p, 
Ad?a, Ad?b, Ad7c) correspond exactly to maps published for these 
strains, with the enzymes 8amHI, Smai, and ~RI, as is il-
lustrated in Figure 4. 
It is clear from Figures 3A (8amHI> and 38 <Smai> that both the 
"1986 May" <Lanes 6) and the 1975 <Lanes 7> isolates yield· the 
same pattern as reference Ad7c <Lanes 5) for both enzymes Cas well 
as to reference. Ad?a <Lanes 3) for Smai>. Similarly, when 
RE profiles of the "1986 May" isolates, digested with the enzymes 
Sal!, Xbai, .!::!...Q.g_I, Hindiii, .ul_I and .ul_II, were compared with 
published maps of' Ad?c for these enzymes <Li, 1986) patterns were 
found to be identical in all cases <results not shown>. The 1975 
Ad? isolate also appeared identical to reference Ad?c by patterns 
of · Sa li , .ul_I and .ul_I I < r e s u l t s not shown ) . However , a f t e r d i -
gestion with EcoRI <Figure 3C> the "1986 May" a.nd 1975 isolates 
(Lanes 6 and 7, respectively> produced patterns that were dif-
ferent both to one another and to those of all Ad? reference 
strains shown <Lanes 2-5>. When compared to the reference Ad?c, in 
addition to EcoRI fragments A and 8 of this strain, the 1975 
isolate has 1 extra EcoRI fragment, while the "1986 May" isolate 
has 2 further fragments: 1 similar in size to that of the 1975 
isolate, and 1 smaller fragment. Since these novel EcoRI restric-
tion fragments appear in both Ad? strains, together with a 
conserved EcoRI 8 fragment, and a Largely intact EcoRI A fragment, 
it follows that 2 extra EcoRI restriction sites, in the case of 
the "1986 May" isolate, and 1 extra site for the 1975 isolate, 
must exist in close proximity either to the Left hand end, or to 
the right hand end of the EcoRI A fragment. 
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Smal 
D H G A c F E 8 7a, 7c 
13·5 19·0 25·4 46·7 61·0 67·6 77-9 97-4 
D G A c F E 8 H 7p 
c G F A E D 8 H 7b 
EcoRI 
A c 8 7a,7p 
85·487·0 
A 8 7c,7b 
Bam HI 
J I H G 8 A E c D F 7p 
2·0 5·2 10·3 16·6 37-2 60·5 70>2 83·1 92·9 
JGHI A 8 E c D F 7a 
79 
JGHI A D c E 8 F 7b 
479 
I FGH A 8 E D c 7c 
FIGURE 4 : 
Restriction site maps <BamHI, Smai, EcoRI> of the genomes of Ad7p, 
Ad7a, Ad7b and Ad7c, given in map units <1 mu = 0.36 kb> 
- Adapted from Wadell et al., 1981. 
3.2.4 Mapping of EcoRI Restriction Sites by Double 
Digestion with EcoRI and Sal! 
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In order to map the positions of the new EcoRI cutting sites in 
the genomes of "1986 May" and 1975 isolates of adenovirus species 
71 2~~ of viral DNA from each of isolate5 2203 <"1986 May"> and 
·2182 (1975> was double-digested with EcoRI and Sali. The resultant 
cleavage products were analyzed by electrophoresis in a 1X agarose 
g e l C F i g u r e 5 ) . A S a li I E c oR I d i g e s t o f Ad 7 c D N A C 2 J...•.g ) w a s 
similarly analyzed for comparison (lane 2>. 
Both new strains of adenovirus species 7.- the 1975 and "1986 May" 
isolates were found to exhibit the same total size of genome 
<-3 6 k b > 1 and nove l c u t t i-n g b y E c oR I on l y i n S a li f r a g me n t C I a t 
the left hand end of the published rest~iction map for Ad7c <refer 
to Figure 8). The "1986 May" isolate <lane 4) showed 3 new frag-
ments < 1.64 kb 1 3.68 kb and 1.01 kb) when compared to the Ad?c, 
control <lane 2>, clearly derived from the 6.34 kb Sal C fragment. 
One EcoRI cutting site must be fixed 3 map units <1.01 kb> to the 
Left of the published Sal! site at 17.5 map units <6.33 kb) which 
would Leave 2 possibilities for the second additional EcoRI site: 
1.64kb or 3.68kb further to the left of this established restric-
tion site. 
Similarly, 2 new fragments of 3.68 kb and 2.65 kb, corresponding 
to the Ad7c 6.34 kb Sal C fragment, were evident in the 1975 
isolate <Lane 3). This established the position of the new EcoRI 
restriction site in this strain : 3.68 kb from the left hand end 
of the Sali fragment c. 
In order to determine the Leng~hs of unknown Ad? restriction 
fragments, A phage DNA C2J...~) was digested with the restriction 
enzyme Psti, and the resultant characteristic fragments separated 
by electrophoresis in parallel with the Ad? digests <Figure 5, 
lane 1). Psti, in contrast to Hindiii, generates several distinct 
~ DNA fragments, in the range of 0.45 - 4.51kb. Thus relatively 
small restriction fragments can be more accurately sized by using 
this enzyme. Fragment Lengths of Ad?-2203 and Ad?-2182 DNA, deter-
mined after single and double digestions with EcoRI and Sal!, are 
indicated in Table 2. 
1 2 3 4 5 
FIGURE 5 
Mapping of EcoRI restric-
tion sites in the genomes 
of w1986 Mayw and 1975 Ad7 
isolates. The figure shows 
electrophoresis of frag-
ments obtained after 
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double digestions with-
EcoRI and Sa1I: 
Lane 1 ?\. Psti digest. 
Lane 2 Ad7-2203 (1986, 
May) 
Lane 3 Ad7-2182 (1975) 
Lane 4 Ad7c <reference 
strain) 
Lane 5 ?-~ Hindiii digest 
(?\. Psti restriction fragments <kb), in order of descending size: 
11.49; 5.08; 4.75; 4.51; 2.84; 2.56; 2.46; 2.44; 2.14; 1.99; 1.70; 
1.16; 1.09; 0.81; 0.51; 0.47; 0.45) 
TABLE 2 Ad7 Restriction Frag•ents Cin kb> Generated by 
Digestion with Sa11 and EcoRI 
I : Ad7ca 
<reference 
strain) 
II Ad7-2203 
III Ad7-2182 
EcoRI 
A 
8 
A 
8 
c 
D 
A 
8 
c 
31.49 
4.71 
26.17b 
4.71 
3.68 
1. 64 
27.80b 
4.71 
3.68 
A 
8 
c 
A 
B 
c 
A 
8 
c 
Sa1I 
18. 14 
11 . 73 
6.34 
18. 14 
11 . 73 
6.34 
18. 14 
11 . 73 
6.34 
EcoRI/Sa1I 
18. 14 
7.02 
6.34 
4.71 
18.00 
7.02 
4.71 
3.68 
1. 64 
1 . 01 
18.00 
7.02 
4.71 
3.68 
2.65 
a Ad7c EcoRI and Sa1I fragment lengths adapted from Wadell et al 
<1981>, and Li and Wadell <1986>. 
b EcoRI A fragment sizes calculated on the basis of a 36.2 kb 
Ad7 genome. 
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3.2:s Conclusion 
Four "1986 May" isolates of adenovirus species 7 <from a small 
hospital outbreak of pneumonia) examined by genome analysis with 
9 different enzymes, were shown to be identical to one another, 
and to the reference Ad7c strain, for all enzymes excluding 
EcoRI.A 1975 Ad7 isolate, similarly examined, also differed from 
reference Ad7c only on EcoRI digestion. While this isolate had 1 
additional EcoRI site, the "1986 May" isolates had 2 further EcoRI 
cutting sites, located at the left hand end of the viral genome in 
Sal! fragment C. Thus, according to the classification system of 
Li and Wadell (1986), which divides different adenovirus species 7_ 
genome types into separate groups on the basis of their BamHI 
restriction patterns, these results have identified two new 
variants of adenovirus genome type 7c, which are named "Ad7c1" and 
"Ad7c2". One isolate, from the "1986 May" group CNr 2203), was 
recently sent to Dr. G. Wadell (University of Ume~. Sweden) for 
identification, and was typed as "Ad7c1" <1986, personal 
communication>. This nomenclature is thus adopted for this strain, 
and "Ad7c2" for the second novel genotype, isolated in 1975. 
3.3. MAPPING OF ADDITIONAL EcoRI RESTRICTION SITES BY DNA 
HYBRIDIZATION 
3.3.1 Introduction 
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By double digestion with the restriction enzymes EcoRI and Sal!, 
i t w-a s s h own t h a t 1 o f t h e add i t i on a L E c oR I s i t e s o f Ad 7 c 1 < " 1 9 8 6 
May" isolates) could be Located on the viral genome in 1 of 2 
possible positions <Section 3.2.4). In order to confirm this 
location, the smaller of the two additional EcoRI restriction 
fragments <EcoRI 0) from Ad7c1 <Nr 2203) was clo.ned' into the 
plasmid vector pUC19, and further used as a radiolabelled probe 
tor hybridization to particular restriction enzyme profiles CSmai 
and EcoRI> of Ad7 DNA immobilised on Hybond- N nylon membranes 
Cloning of this fragment enabled it to be amplified at high ef-
ficiency in the form of recombinant plasmid DNA. It also served to 
eliminate possible contamination from remaining viral sequences 
Cor from HF DNA) prior to hybridization analysis. 
3.3.2 Cloning of Ad7c1 EcoRI D Fragment 
Two new EcoRI restriction fragments, EcoRI C and D, were 
demonstrated in Ad7c1. Of these, one was Located at the extreme 
Left hand end of the viraL genome and one alongside this and to 
the Left of EcoRI fragment A. However, the orientation of these 
restriction fragments with respect to one another remained 
unknown. The cloning strategy adopted was based on the assumption 
that restriction fragments at the extreme ends of the viral 
genome, and thus bordered by only one restriction enzyme site 
would not be cloned. This shotgun approach involved Ligation by 
combining total viral DNA <Ad7c1 cleaved with EcoRI) with single 
stranded vector DNA CpUC~9 cleaved with the same enzyme) assuming 
that a more centrally Located Ad7c1 EcoRI fragment would be selec-
tively cloned <Section 2.6). One would not expect to clone EcoRI 
fragment A of Ad7c1 as this is 26 kb in Length, and thus too Large 
for the plasmid vector of choice, namely pUC19. This vector can 
only be used efficiently tor cloning relatively small DNA inserts, 
Less than 10 kb in Length, but would be suitable for a putative 
3.68 kb or 1.64 kb Ad7c1 viral insert. 
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From 2 experimental Ligation reactions, using 100ng of pUC19 DNA, 
and an equimolar ratio of insert and vector DNA, 20 white colonies 
containing potential recombinant plasmids were derived. Twelve of 
these colonies, randomly selected, and screened using a rapid 
"miniprep" method of plasmid preparation <Birnboium and Doly, 
1979) and subsequent EcoRI digestion, were all found to harbour an 
identical recom~inant plasmfd- pUC19 <2.6 kb) containing a 1.64 
kb Ad7c1 viral insert, cloned at the EcoRI restriction site. One 
of these 12 was again sel~cted and the recombinant plasmid, named 
pAd7c1EcoD, was amplified on a Large scale by growth in E.coli 
JM107, and purified in a CsCl density gradient. 
The selective cloning of this 1.64 kb Eco D fragment indicates 
that the linear order of the EcoRI fragments on the Ad7c1 genome,-
should be CDAB. This was confirmed by subsequent hybridization 
. analysis (Section 3.3.3). 
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3.3.3 Hybridization Using the Cloned Ad7c1 EcoRI D Fragmeni 
The cloned Ad7c1 EcoRI D fragment <1.64 kb) excised by EcoRI 
cleavage from the purified recombinant plasmid pAd7c1EcoD (4.24 
kb) is in~icated in Figure 6A. The viral DNA insert was purified 
from vector DNA sequences by digestion of the purified plasmid DNA 
( 4- 5 "-lQ ) w i t h E c oR I , and s u b s e q u en t p r epa r a t i v e e L e c t r o ph o r e s i s i n 
a 0.8X agarose gel. Recovered insert DNA <1-2 J-.lQ) could then be 
r~diolabelled by nick-translation in the presence of a 32P dCTP 
(to a specific activity of 1 x 108 dpm/J-.lQ DNA>. EcoRI restriction 
enzyme profiles of the 3 Ad7 genotypes <Figure 68>, Ad7c-
<reference strain), Ad7c1 and Ad7c2, immobilised on a hybond-N 
nylon membrane, were probed with this radiolabelled EcoRI D frag-
ment <Figure 6C). Hybridization to the Large EcoRI A fragment is 
clearly shown in Lane 3, for reference Ad7c, and also in Lane 1, 
for Ad7c2, but only to EcoRI D in Lane 2 for control Ad7c1. This 
verifies the Location of the novel EcoRI restriction site in 
Ad7c2, at 10.2 map units, or 3.68 kb from the Left hand end of the 
viral genome. 
In order to confirm the predicted EcoRI restriction map for Ad7c1 
(Section 3.3.2), a Smai restriction enzyme profile of Ad7c1 DNA, 
transferred onto Hybond-N nylon membrane, was probed ~ith a 
s i m i L a r r ad i o L abe L L e d Ad 7 c 1 E coR I D probe < F i g u r e 7 A ) . T h i s i den·-
tified 2 Smai restriction fragments, D and H, which must overlap 
with EcoRI fragment D. As the Leftmost Smai restriction site of 
Ad7c1, <separating fragments D and H) is Located at 13.5 map 
units, this indicates that the 2 EcoRI restriction sites, border-
ing the cloned 1.64 kb fragment, must be Located on either side of 
this map position: at 14.7 map units, and 1.64 kb to the left of 
this site at 10.2 map units <Figure 78). 
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FIGURE 6 
Hybridization of Ad7c1 Eco D fragment to Ad? DNA, digested with 
EcoRI. The cloned Eco D fragment (1.64 kb), released from pUC19 
vector DNA <2.6 kb) by cleavage with EcoRI, is indicated in F i gure 
6A, Lane 2. < ~ DNA digested with Hindi!! is shown in Lane 1 ~ as a 
molecular weight reference). 
Figure 68 shows EcoRI 
analyzed by agarose gel 
gel, probed with the 
Lustrated in Figure 6C. 
restriction enzyme profiles of Ad? strains 
electrophoresis; an autoradiograph of this 
radiolabelled EcoRI fragment D, is il-
Lane 1 
Lane 2 
Lane 3 
Ad7c2 <Nr . 2182) 
Ad7c1 <Nr.2203) 
Ad7c <reference strain) 
A 
A 
B 
c 
D 
E 
F 
G 
H 
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1 2 
B Smal 
FIGURE 7 
Hybridization 
Smai. Figure 
agarose gel 
radiolabelled 
site maps of 
Figure 78 . 
D H G A c F E B 
I I I I I I I 
I 
I 
46 ·7 61 67·6 77·9 97·4 113-5 1 19 25·4 
c 102 0 14-1 A 87 B 
EcoRI 
of Ad7c1 Eco D fragment to Ad7c1 DNA, digested with 
7A shows a Smai profile of Ad7c1 DNA, analyzed by 
electrophoresis <Lane 1), and by hybridization to a 
Eco D probe <Lane 2). Smai and EcoRI restriction 
the Ad7c1 genome <in map units) are indicated in 
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3.3.4 Conclusion 
In conclusion, the positions of new EcoRI restriction sites in the 
genomes of 2 new variants of adenovirus genome type 7c, designated 
Ad7c1 and Ad7c2, have been determined. Resultant EcoRI <and Sali) 
restriction maps are illustra~ed in Figure 8. 
7c 
FIGURE 8 
c 17.5 A 
A 
c 17.5 A 
... 
c 10.2 ······························~············ .... , 
3.68 Kb 
(Eco R1 C) 
c 17.5 A 
c1o.204_7 ··············· A 
2.65 Kb 
67.6 
67.6 
67.6 
····························· ... , 
3.68 Kb 1.64 Kb 1 1.01 Kb 
(Eco R1 C) (Eco R1 D) 
8 
87 8 
8 
87 8 
8 
87 8 
Sal 1 
Eco R1 
Sal 1 
Eco R1 
Sal 1 
Eco R1 
Res t r i c t i on s i t e maps < sa 1 I , S£.Q..R I > o f t h e genome s o f Ad 7 c , Ad 7 c 2 
and Ad7c1, given in map units. An expanded scale, in kilobases, is 
shown for the Sa1I C fragments of Ad7c2 and Ad7c1. This il-
lustrates the location of the additional EcoRI cutting sites at 
3.68 and 5.32 kb <14.7 mu> of Ad7c1 and at 3.68 kb of Ad7c2. 
<EcoRI and Sa1I maps of Ad7c taken from Wadell et al., [19811 and 
Li and Wadell (19861>. 
3.4. COMPARISON TO OTHER LOCAL AND JOHANNESBURG ISOLATES 
OF ADENOVIRUS SPECIES 7 
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In order to compar~ these newly identified genome types of 
Adenovirus species 7 to other Ad? isolates, a further group of 19 
isolates, from both Cape Town and Johannesburg, were iden~ified by 
restriction endonuclease analysis, using BamHI, Smai and EcoRI. 
The results of this survey are summarized in Table 3. 
The first group of 11 Johannesburg isolates, obtained from Dr. A. 
Kidd at the National Institute for Virology (Johannesburg>, were 
recent isolates from 1985 <7> and 1986 <4>. From the 1985 group, 
1 was shown to be an adenovirus prototype 7c <Nr 2084>, while the 
remaining 6 were aLL identical to 'ou~ new variant Ad7c2 (Nrs 2154, 
2168, 2156, 2153, 1980 and 1727> with regard to restriction enzyme 
profiles with BamHI, EcoRI and Smai. Of the 1986 isolates, two 
were adenovirus prototype 7c genotypes <Nrs 274 and 548), while 
the Last two <Nrs 702 and 1004), apparently unlike any previously 
identified Ad? genome type, were identified as adenovirus type 34 
<subgenus 8:2) genotypes, by comparison with previously published 
restriction maps for the enzymes BamHI and Smai <Adrian, 1986). 
Representative restriction enzyme profiles of each of these iden-
tified genome types are illustrated in Figure 9. The strain shown 
in Lanes 4 is an Ad7b reference strain, which was included as a 
control. 
In concurrent studies in our Laboratory, 8 additional Cape Town 
isolates of Ad? have been grown and identified, after genome 
analysis. with the same 3 enzymes- BamHI, EcoRI and Smai. One of 
these, a 1976 Ad? isolate CNr 655) was found to be identical to 
our previously i-dentified 1975 isolate <Nr 2182), and was typed as 
an Ad?c variant, Ad7c2. Both of these were single Lung isolates 
from young children from the same ward at the Red Cross Hospital 
as the "1986 May" group, who died of post measles pneumonia. Four 
1985 Cape Town isolates CAK1, AK2, AK3 and AK4> obtained from Dr. 
A. Kidd <NIV, Johannesburg> were similarly identified as Ad7c2 
genome types. These were associated with a small outbreak of acute 
respiratory infection in 4 children with post measles pneumonia. 
Two further 1985 Ad? isolates from our Laboratory- 1 from a child 
with post measles pneumonia (Nr 4822> and 1 from a child with 
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myocarditis (Nr 3383>, both of whom died- were both typed as 
adenovirus 7 prototype <Ad7p> genotypes. Restriction enzyme 
profiles of these strains are indicated in lanes 1 and 2 of Figure 
9. One recen~ October 1986 Ad? isolate <Nr 4412) was from a child 
with post measles pneumonia, in the same ward at the Red Cross 
Childrens' Hospital as our previously identified 4 "1986 May" 
isolates <identified as Ad7c1 genotypes). This isolate, however, 
was shown to be an adenovirus "reference-like" 7c (Ad7c> strain. 
TABLE 3 Genome Types of Ad-7 Isolated During the Period 1975-86 
Specimen Nr. 
I : CAPE TOWN ISOLATES 
2182 
655 
AK1 
AK2 
AK3 
AK4 
3383 
4822 
2256 
2203 
2314 
2332 
4412 
Isolation Date 
1975 
1976 
1985 
1985 
1985 
1985 
1985 
1985 
1986, May 
1986, May 
1986, May 
1986, May 
1986, October 
I I JOHANNESBURG ISOLATES 
2154 1985 
2168 1985 
2156 1985 
2153 1985 
1980 1985 
1727 1985 
2084 1985 
274 1986 
548 1986 
702a 1986 
1004a 1986 
a: Specimens 702 and 1004 were typed as 
serum neutralization. 
Genome Type 
adenovirus 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7p 
Ad7p 
Ad7c1 
Ad7c1 
Ad7c1 
Ad7c1 
Ad7c 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c2 
Ad7c 
Ad7c 
Ad7c 
Ad34 
Ad34 
species 7 by 
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EcoR I Smal Bam HI 
FIGURE 9 
Representative restriction enzyme profiles <BamHI, Smai and EcoRI) 
of Ad7 strains, isolated in Cape Town and Johannesburg, in 1985 
and 1986. 
Lanes 1 
Lanes 2 
Lanes 3 
Lanes 4 
Lanes 5 
Lanes 6 
Lane 7 
Ad7 - 3383 (1985) 
Ad7 - 4822 (1985) 
Ad7 - 1980 (1985) 
Ad7b reference strain 
Ad7 - 702 (1986) 
Ad7 - 548 (1986) 
~ Hindi!! digest, as molecular weight 
reference. 
4 DISCUSSION 
To date 41 human adenovirus species, divided into 7 subgenera, 
have been recognized. Of these, members of subgenus B, and in 
particular, adenovirus 7, is most frequently associated with 
severe disease and epidemic outbreaks of systemi~ infections. In a 
recent survey of the worldwide distribution of Ad? genome types, 
Wadell et al. (1985) have demonstrated a preponderance of Ad7c and 
Ad7b in both Europe and Australia. Ad7c was the dominant genome 
type of adenovirus 7 in the years before 1970-1975, in both Europe 
and· Australia. Thereafter a shift from Ad7c to Ad7b was shown to 
occur, and in the Last decade this genome type CAd7b) has 
predominated in Europe, Australia and North America. Twenty-two 
South African Ad? strains isolated during the period of 1967 to 
1976, and obtained from Dr. B.D. Schaub CNIV, Johannesburg), were 
also analyzed in this survey. The earliest strain was identified 
as Ad7b while all the rest were Ad7c genome types. 
~e have analyzed a total of 24 different isolates of adenovirus 
species 7, 9 of which were isolates from our Laboratories, while 
15 were obtained from Dr. A. Kidd at NIV, Johannesburg. In this 
study 2 new genome types of adenovirus 7 have been identified~ and 
according to restriction enzyme patterns with EcoRI <and based on 
the classification system of Li and Wadell [1986)), these are 
variants ·of adenovirus genome type 7c. The Ad7c strains reported 
here from 1975 and 1976 <Nr 2182 and Nr 655) were identical to one 
another, but had· 1 extra EcoRI restriction site Cat 10.2 map 
units) when compared to reference Ad7c. A second novel Ad7c 
~ariant isolated in 1986 CNrs 2256, 2203, 2314 and 2332) exhibited 
a second additional EcoRI cutting site at 14.7 map units. A total 
of 18 different genome types of Ad? have recently been described 
<Li, 1986; Bailey, 1986), but no variants of Ad7c have yet been 
reported. One of our isolates, from the "1986 May" group <Nr 
2203), has been identified by Dr. G. Wadell <University of Umea, 
Sweden) as "Ad7c1" <personal communication). This nomenclature was 
therefore adopted for the "1986 May" strain, and "Ad7c2" for the 
genotype isolated in 1975 and 1976 <and subsequently in 1985). 
There did not appear to be a difference in the virulence of these 
39 
genotypes when compared to prototype Ad7c. The majority of iso-
Lates were associated with cases of post measles pneumonia in 
children Less than 12 months of age. 
While analyses 
existence of 
of 
Ad7c2 
Cape Town Ad7 'isolates have identified the 
during the period of 1975-1985, and Ad7c1 in 
May 1986, the recent identification of the proto~ype Ad7c strain 
CNr 4412>, isolated from the same ward as the four "1986 May" 
strains, must indicate the continued co-circulation of different 
genome types of adenovirus species 7. Similarly, comparison with 
Johannesburg Ad7 strains has revealed the existence of Ad7c2 in 
1985 isolates, and the prototype Ad7c genotype in 1985 and 1986. 
While the Ad7c genome types are clearly still prevalent in South 
Africa, it has been suggested that Ad7b and Ad7c alternate over 
the decades as the aetiological agents in Ad7 respiratory out-
breaks <Wadell, 1981). 
We have also identified the Ad7 prototype <Rowe et al., 1958) in 
2 1985 Cape Town isolates <Nr 3383 and Nr 4822). This genome type 
is infrequently isolated, and .together with Ad7a represents the 
major portion of the Ad7 strains isolated f~om healthy carriers 
<Wadell et al., 1985). While Ad7p is thought to be Less virulent 
than the Ad7b and Ad7c genome types <Wadell et al., 1985), it is 
noteworthy that both of our 1985 Ad7p isolates were associated 
with symptoms of severe Ad7 infection, resulting in death. This 
genotype has also recently been identified in a number of 1987 
isolates from our Laboratory. 
Restriction endonuclease analyses of 2 of the Johannesburg iso-
Lates <Nr 702 and Nr 1004) revealed their identities as Ad34, and 
not Ad7 genome types. Both isolates had previously been typed as 
Ad7 strains by neutralization. This result was surprising in view 
of the fact that prototype Ad34 and Ad7 strains have been reported 
to exhibit no cross-reaction in standard neutralization and hemag-
glutination inhibition reactions <Wigand et al., 1985). The a 
species of human adenoviruses grouped into subgenus B have been 
separated into 2 clusters of DNA homology <Wadell et al., 1980), 
the first (8:1) containing Ad3, Ad7, Ad16 and Ad21, and the second 
<B:2) containing Ad11, Ad14, Ad34 and Ad35. Since subgenus 8:2 
members are rarely isolated, accounting for Less than 1~ of all 
reported adenovirus isolated <Schmitz et al., 1983), the reported 
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frequent shedding of Ad34 and Ad35 in patients with acquired 
immunodeficiency syndrome <AIDS) has stimulated much interest <de 
Jong et al., 1983). These 2 species are characteristically iso-
Lated from immunocompromised patients, renal and bone marrow 
transplant patients, and AIDS patients <Wigand·, 1985). DeJong ll.. 
a L . < 1 9 8 3 ) h ave em p h a s i z e d t h e i m p or t an c e o f c h a r a C· t e r i z i n g 
adenovirus isolates, often found in the urine of AIDS patients, 
both serologically and by restriction endonuclease analysis. They 
were able to demonstrate the existence of new Ad-35-Like 
viral isolates, derived from the recombination between a small 
part <40X) of the Ad7 genome, coding for the fiber polypeptide, 
and greater than 90% of the Ad35 genome. <The two kinds of type 
specific determinants on the adenovirus particle, which are 
measured by neutralizatiori assays, are carried by hexons and 
fibers [Wadell et al., 19801>. "Thus, it is possible that the 
"Ad34" strains <Nr 702 and Nr 1004) reported here are similar 
Ad7/Ad34 recombinants that neutralize with Ad7 antiserum, but show 
restriction patterns ide~tical to Ad34. This hypothesis would need 
to be tested, by analysis with additional restriction enzymes that 
cut differentially near the right end of the viral genome, in the 
regions encoding the fiber <86-91 mu> and hexon <S0-59 mu) 
polypeptid~s <de Jong et al., 1983). 
Due to the Large number of adenovirus species <41 at present), and 
th~ variability in restriction patterns within ea~h ~pecies, 
restriction endonuclease analysis is not generally employed for 
the routine typing of adenovirus isolates. However, methods have 
been developed to fa~ilitate the rapid analysis of large numbers 
of isolates <Lehtomaki et al., 1986; Suzuki et al., 1981; Brown et 
al., 1984; Fife et al., 1985) and the unique advantages <such as 
speed and accuracy) of this form of virus typing over standard 
neutralization techniques have been reported. In conclusion, 
restriction endonuclease ~nalysis has allowed us to identify and 
to characterize 2 new adenovirus species 7 genome types, and 
further to assess their importance with regard both to epidemiol-
ogy and to pathogenicity. 
PART II 
OESOPHAGEAL CARCINOMA - SEARCH FOR A POSSIB
LE VIRAL AETIOLOGY 
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1. INTRODUCTION 
Cancer of the oesophagus is presently the Leading cause of cancer 
deaths among the black population of Southern Africa <Bradshaw and 
Harington, 1986). The incidence of this disease shows a striking 
geographical Localization, and in certain regions of the country 
rates have bee~ reported to be higher than any other known cancer 
anywhere in the world (Gillis and Hole, 1978>. 
Although oesophageal carcinoma has been common in certain sharply 
defined areas of China <Yang, 1980> and Iran <Hormozdiari et al., 
1975) for centuries, its incidence among the black population of 
Southern Africa remained insignificant until. the Late 1940's. 
Since then, however, it has reached epidemic proportions, par-
ttcularly in the Transkei~ and it appears to be increasing in 
other parts of the country among both the urban and the rural 
population <Kneebone and Mannell, 1985). Even within the Transkei, 
a marked degree of regional variation in incidence has been 
reported, ranging from 2 cases per 100 000 in th·e Bizana· district 
in the north to 116 cases per 100 000 in the Butterworth area in 
the south <Morris and Price, 1986). 
1 .1 AETIOLOGY 
The aetiology and pathogenesis of carcinoma of the oesophagus are 
the subjects of extensive investigation. While several factors 
have been implicated as aetiological agents, no common cause has 
been described for all geographical areas associated with a high 
incidence of this tumor, and the involvement of multiple factors 
with the disease has been suggested. Certain of the more favoured 
aetiological agents are briefly discussed in the following 
sections. 
1.1.1 Dietary Pattern 
Since all ingested substances have contact with the oesophagus, 
diet is clearly of importance when investigating tumors of the 
oesophagus. A dietary effect could be brought about either by the 
ingestion of carcinogenic agents such as nitrosamines and fungal 
toxins, 'or by some dietary deficiency. Extensive studies h~ve been 
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carried out to compare the staple diet of populations at high or 
low risk for oesophageal cancer <van Rensburg, 1981). In all high 
risk areas the dietary staple was found to be maize and/or wheat. 
An examination of the chemical composition of these foods revealed 
that such a "high risk" diet was deficient in respect of 2 8 
vitamins, nicotinic acid and riboflavin, and also 2 essential 
minerals, magnesium and zinc. A combined deficiency in the first 2 
vitamins could damage the oesophagus and perhaps predispose to 
malignancy <Warwick and Harington, 1973). Such "promoting" damage 
to the oesophageal mucosa, which can also be brought about by 
mineral deficiencies, would appear to be an early event in the 
onset of oesophageal carcinoma, followed by specific carcinogenic 
induction <Bradshaw and Harington, 1986). 
1.1 .2 Potential Carcinogens or Co-Carcinogens 
1.1.2.1 Alcohol and tobacco 
While alcohol and tobacco have been implicated as risk factors in 
South Africa <van Rensburg, 1985) they are thought to be u~impor-
tant in the high risk regions of Iran CHormozdiari et al., 1975). 
The use of alcohol is known to increase the requirements of the 
abovementioned nutrients, and it could thus mediate its effect via 
nutritional deficiencies. Alternatively, it may have a dehydrating 
effect on the oesophagus, and in this way damage it <Warwick and 
Harington, 1973>. There has been shown to be a correlation between 
carcinoma of the oesophagus and the smoking of unprocessed, 
sundried tobacco <Warwick and Harington, 1973). Transkei tobacco 
was found to be particularly mutagenic and to contain a higher 
than usual content of nitrate and nitrosamines CRose, 1982>. 
1.1.2.2 Nitrosamines 
Nitrosamines are site specific carcinogens in many experimental 
animals <Warwick and Harington, 1973). Traces of some nitrosamines 
which are implicated in liver cancer, and others which are in-
volved in oesophageal cancer in animals were found in many food 
and beer samples from the Transkei, although thsre were no strik-
ing differences in the absolute levels between low and high 
incidence districts <Rose, 1982). At present there is not enbugh 
evidence to support a role for these compounds as a major cau~e in 
the genesis of oesophageal carcinoma. 
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1.1.2.3 Mycotoxins 
Van Rensburg <1985) has proposed that the only possible source of 
the carcinogens and promoters common to all endemic regions 
originates from heavy fungal disease of food crops. In the 
Transkei maize is the monostaple food and the base for much of the 
beer brewed in great quantities. This crop has frequently been 
found to be infected with the fungus, Fusarium moniliforme, both 
in the Transkei and fn C~ina, while in Iran frequent infection of 
wheat by Alternaria alternata has been described (Marasus, 1982). 
These fungal contaminants were shown to exhibit a higher incidence 
in high as-opposed to low rate areas of oesophageal cancer. ~hile 
the nature of the carcinogenesis-enhancing substances in the 
fungal cultures are not known, both of these fungi were found to 
enhance tumor development when fed to laboratory rats which had 
received small doses of cancer-inducing nitrosamines <van 
Rensburg, 1985; Jaskiewicz, 1987). Much of this recent evidence 
points to a significant role for mycotoxic activity in the aetiol-
ogy of oesoph~geal carcinoma. 
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1.2 THE POSSIBLE ROLE OF ONCOGENIC VIRUSES 
While the roles of the abovementioned factors <nutritional 
deficiency, dietary habit and carcinogenic exposure) in the 
aetiology of oesophageal cancer cannot be excluded, they are 
believed to be insufficient to explain the striking regional 
variations in the incidence of th~s neoplasm, or the increase in 
it's incidence in the Last 25 years. A high incidence of par-
ticular malignant tumors, in well defined geographical areas, is 
often associated with viral aetiological factors. For example, 
there is a statistical correlation between infection with 
Hepatitis B virus and the development of primary Liver cancer, 
especially in T~iwan and parts of Africa. Furthermore, Epstein-
Barr virus has been epidemiologically Linked to Burkitt's Lymphoma 
in central Africa and to nasopharyngeal carcinoma in South-East 
Asia. The retrovirus human T-lymphotropic virus <HTLV-1} has been 
implicated in the pathogenesis of adult T-cell Leukemia, espe-
cially in the Southern Islands of Japan. The association of 
carcinoma of the oesophagus with certain geographical areas· thus 
suggests a possible viral aetiology for this tumor. 
Possible oncogenic DNA viruses that could be involved in the 
aetiology of oesophageal carcinoma are discussed in the following 
sections. These viruses are: adenoviruses, papillomaviruses, and 
Epstein-Barr virus. Probes from these viruses were used in the 
survey of oesophageal tumor cells described in Later sections of 
this work. 
1 . 2. 1 Human Adenoviruses 
The human adenoviruses are medium-sized viruses containing a 
Linear double-stranded DNA genome, 33-45 kilobases in Length. 
Forty-one serotypes of human adenoviruses have thus far been 
identified. These are classified into 7 subgenera, A-G <refer to 
Part I, Table 1), the members of subgenus A <Ad12, Ad18, Ad31) 
being highly oncogenic in animals, and those of subgenus B <Ad3, 
Ad7, Ad14, Ad16, Ad21, Ad34, Ad35) weakly oncogenic; the members 
of subgenera c to E are nononcogenic but together with those of 
subgroups A and B, will readily transform rodent cells in culture 
to a neoplastic phenotype. 
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1.2.1.1 Association with human disease 
Most humans are infected early in Life by several of the common 
human adenoviruses. Infections with subgenus A members are rela-
tively common and are mainly associated with gastrointestinal 
disease in young children. While subgenus 8:2 members CAd11, Ad14~ 
Ad34, Ad35) are relatively rarely isolated, the members .of sub-
genus 8:1 CAd3, Ad?, Ad16, Ad21> appear in epidemic outbreaks of 
conjunctivitis and/or respiratory disease, and can cause fatal 
infections in children under 2 years of age <Part I, Section 1.3>. 
The subgenus c adenoviruses are the most prevalent. They cause 
predominantly mild infections of the upper respiratory tract and 
readily form Latent infections in lymphoid tissues. In contrast to 
these, and the fastidious. adenoviruses of subgenera F and G, 
<isolated in large quantities from cases of infantile diarrhea), 
subgenus D and E members are very rarely isolated CWadell, 1986). 
The fact that adenovirus species of subgenera A,8:2 and C, with 
predilect.ions for persistent infections, can cause severe or 
Lethal infections in immunocompromised patients is well known. 
Although to date extensive studies have failed to show an associa-
tion between adenoviruses and any type of human cancer (Green and 
Mackey, 1977; Green et al., 1980), these viruses do have oncogenic 
properties and it is therefore possible that they could play some 
role in human cancer. The reported frequent shedding of Ad34 and 
Ad35 in the urine of patients with acquired immunodeficiency 
syndrome <AIDS>, may be significant <de Jong et al, 1983). In this 
study, adenovirus was 
patients than from a 
isolated at a much higher rate from AIDS 
comparable group of renal transplant 
patients, 
This is 
and one particular genotype - Ad35 - was represented. 
difficult to ex~Lain simply in terms of the reactivation 
of Latent virus as a consequence of immunosuppression. 
1.2.1.2 Cell transformation 
Human adenoviruses can malignantly transform a variety of rodent 
cells grown in culture, although these cells are either semiper-
missive, or completely nonpermissive to viral replication. Human 
cells, which are fully permissive to adenovirus replication, are 
extremely difficult to transform. In fact, only 2 transformed 
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human cell liries have been isolated to date: an AdS transformed 
embryonic kidney cell line, the 293 linej and an Ad12 transformed 
human retinoblast line <van der Eb and Bernards, 1984). The left 
hand (5') 15~ of the viral genome is. known to contain the early 
region E1, transcribed in the early phase of lytic infection, and 
to encode the transforming genes of nononcogenic AdZ and AdS, 
weakly oncogenic Ad3 and Ad7, and highly oncogenic Ad12 and Ad31 \ 
<van der Eb and Bernards, 1984). The respective E1 regions of 
these different species are organized in a very similar way, as 
shown in Figure 10. They comprise two adjacent transcriptional 
units, E1A <1.3-4.5~> and E1B <4.6-11.5~>. encoding proteins 
involved in transformation. 
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FIGURE 10 
Organization of the transforming region E1 of human adenovirus 7. 
The two subregions E1A and E1B are indicated. The figure shows the 
leftmost 17~ of the Ad7 Grider strain DNA, including the Hindi.II 
IJ region <0-2.72 kbp) with transforming activity. 
Adapted f~om Fujinaga et al. (1984). 
Although t r a n s ·f e c t i o n of cells 
' 
w_ith E1A sequences alone will 
. 
. 
(, 
result in partial transformatio~, th~se cells are not tumorigenic. 
In contrast, cells transformed by the E1 region are both fully 
transformed and tumorigenic <Berk, 1986). Thus E1A functio~ is 
central to adenovirus induced transformations although the exact 
mechanism invol~ed is not yet fJlly und~rstood. 
While proteins encoded by region E1B play a cooperative part in 
the transformation process, they cannot alone induce alterations 
in cell growth or morphology. Two major p~otein products, 55K and 
19K proteins, are encoded by the E1B region. The 19K product is 
essential for adenovirus mediated cell transformation, and is 
thought to be the major transforming protein. However, the SSK 
. 
protein does influence the frequency of tumorigeni~ity of the 
transformed cells, in a species specific manner <Stillman, 1986). 
As for the E1A proteins, the exact role these 2 proteins play in 
transformation by adenoviruses is not yet fully understood. 
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1.2.1.3 Integration of the viral genome 
In most tumors and transformed cell Lines induced by adenovirus, 
multiple copies of viral DNA and/or viral DNA fragments are found 
integrated into the host cell genome, and are present in non-
stoichiometric amounts. There is no evidence that specific host or 
viral DNA sequences are involved in this process. Continuous 
expression of viral transforming DNA sequences seems to be re-
quired for the maintenance of the transformed state·, but it is 
also not clear whether specific integration<s> is required for the 
the establishment and/or maintenance of transformed phenotypes 
<Fujinaga et al., 1984). 
1. 2. 2 Epstein-Barr Virus 
Epstein-Barr virus <EBV) was originally described by Epstein et 
~ (1964) who discovered the virus in cultured Lymphoblasts 
derived from African patients with the B-cell lymphoma, Burkitt's 
Lymphoma <BL>. This Large virus, a member of the human herpesvirus 
group, contains a Linear double-stranded DNA genome, 172kb 
in Length. Studies on EBV have been seriously hindered by the Lack 
of a tissue culture system that will allow Lytic infection. 
1.2.2.1 Association with human malignant diseases 
EBV has been strongly associated with two malignant diseases in 
man, Burkitt's Lymphoma and nasopharyngeal carcinoma <NPC), and in 
1968 it was shown to be the causative agent of a third common 
disease,infectious mononucleosis <Ernberg and Kallin, 1984). 
Burkitt's Lymphoma is a highly malignant tumor which has a high 
incidence both in tropical Africa and in New Guinea. It occurs 
with much Less frequency, no~ always Linked to EBV, in other parts 
of the world. ALL malignant a-Lymphocytes, whether associated with 
· EBV infection or not, show a reciprocal 8 to 14 chromosomal trans-
Location, or a variant translocation of chromosome 8 to chromosome 
2 or 22. The fact that in all translocations the c-~oncogene 
has been identified at or near the breakpoint of the chromosomal 
translocation suggests j that the activation or deregulation of 
this gene could be -the key event leading to the malignant 
phenotype (Lenoir, 1986). 
In contrast to uniclonal BL cell Lines, polyclonal Lymphoblastoid 
cell Lines <LCL's), that are derived after EBV infection of human 
B Lymphocytes in vitro. are neither tumorigenic in immunosup-
pressed animals, and nor do they exhibit these non-random 
chromosomal translocations (Lenoir 1986>. 
T~us, while it is almost certain that EBV plays a causative role 
in endemic BL, it is cle~rly not absolutely necessary nor suffi-
cient in itself for malignant degeneration. The fact that every 
cell in African Burkitt's tumors is infected with EBV strongly 
suggests that viral infection preceeds malignant proliferation. It 
has been proposed that EBV primes the cell for malignant transfor-
mation by promoting proliferation, and that the influence of some 
co-carcinogenic factor further promotes the emergence of the 
malignant ·B-cell CKieff et al., 1982). Since the high incidence 
areas of BL are also the only areas in the world where malaria is 
hyperendemic, a chronic malaria infection has Long been thought to 
represent this co-factor <Epstein, 1984). Malaria is not only 
immunosuppressive, but it is also able to stimulate B-cell 
proliferation. A second hypothesis is that African EBV. isolates 
differ from other EBV isolates, and in analogy to human papil-
Lomavirus <Section 1.2.3), specific subtypes are associated with 
the malignant disease and others associated with nonmalignant 
conditions induced by the virus. However, Bornkamm et al. (1984) 
have addressed this question and found no apparent difference in 
the EBV genomes carried in Burkitt tumor cells and those carried 
in nonmalignant lymphoblastoid cells from the same individuals. 
The second EBV associated human malignancy, nasopharyngeal car-
cinoma, occurs infrequently in most populations, but has a high 
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incidence in southern China. EBV DNA has been demonstrated in the 
epithelial carcinoma cells of these tumors, and this provides 
definitive evidence that the host range of the virus in humans is 
broader than 8-Lymphocy.tes. Both environmental and genetic factors 
have been implicated as aetiological agents in the pathogenesis ot 
the diseas~ CKieff et al., 1982>. 
1.2.2.2 The intracellular EBV genome 
It has not yet been determined whether integration of EBV into the 
host cell genome is an important primary event during 
tumorigenesis. Each BL-derived cell Line has been shown to carry a 
constant number of copies of the EBV genome from one generation to 
another, and the majority of these are episomal. However, direct 
evidence in favour of EBV integration does exist in the case of 
the Long established BL cell Lines Raji <Anvret et al., 1984) and, 
Namalwa <Matsuo et al., 1984). In contrast, Harris et al. C1985) 
have analyzed three recently isolated BL derived cell Lines, and 
have demonstrated the close association of EBV DNA with metaphase 
chromosomes of the host cell. However, this association did not 
involve covalent Linkage, suggesting that EBV integration might 
not be of primary importance in the genesis of the tumor. 
1.2.2.3 Cell transformation and antigen expression 
In contrast to cells transformed by· adenoviruses or papovaviruses, 
the entire EBV genome is present in cells transformed by this 
virus. These infected cells regularly express a restricted set of 
viral genes, some of which must be responsible for the induction 
and maintenance of cell proliferation. In analogy to the papova 
and adenoviruses, these genes are Likely to be continually ex-
pressed in the proliferating cell. 
The Linear EBV genome C172kb> 
sequence complexity, U1-U5, 
is divided into 5 domains of unique 
bounded by direct tandem copies of 
repeated DNA sequences Located at the termini, TR, and at internal 
sites within the molecule, IR1-IR4 (Figure 11). F~nctions in 
cellular transformation have been proposed for proteins encoded by 
4 different viral genes CLT1-LT4), but the exact roles these 
proteins play have not yet been elucidated CDambaugh et al., 
1986). 
U2 
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FIGURE 11 
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Schematic diagram of Linear EBV DNA C172kb) showing the organiza-
tion of unique CU1-5) and major tandem repeat CIR1-3> DNA domains. 
The Locations of four major transcripts CLT1-4) expressed in 
Latent, immortalizing infection are shown. The discontinuity in 
the genome reflects a deletion in the B95-8 strain of EBV. 
Adapted from Dambaugh et al. (1986). 
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1.2.2.~ EBV infection of epithelial cells 
While· EBV has been classical.ly regarded as a strict
ly B-
lymphotropic agent, there is now a growing body of ev
idence 
suggesting that epithelial. cells may be infected by this 
virus. 
Although its association with malignant cells of NPC has lon
g been 
known, more recent studies have reported the detection 
of the 
viral genome in lymphoepitheliomas of the salivary glands 
and of 
.the thymus <Young et al., 1986>. Furthermore, evidence f
or the 
existence of functional EBV receptors on human epithelia
l cells 
lining the mouth and. the pharynx <as .well as on ectoce
rvical 
epithel.ial cells> has recently been reported <Young et al, 
1986>. 
Sixbey et al. <1983> have also demonstrated that certain 
human 
epithelial cells 
infection, unlike 
vir~s productive 
epithelial cells 
infected in vitro will sustain a productive EBV 
the LCL's which can seldom be induced into a 
cycle. These results suggest that infection of 
could be crucial both to the events of primary 
infection and to the mechanism of virus persistence in the 
immune 
host. 
It would, however, appear that the mechanism of. cellular tr~
nsfor­
mation by EBV is not the same for epithelial cellS and 
for a-
lymphocytes. Gr~ffin and Karran <1984) have r~cently described the 
immortalization of monkey kidney epithelial cells by cloned
 viral 
DNA derived from the rfght hand <3') end of the viral genome. This 
region did not include any of t~e 4 regions of EBV DNA shown
 to be 
~xpressed in virus-immortalized B-cells <Section 1.2.2.3>. 
I 
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TABLE 4 Papillomavirus Types and Associated Lesions 
HPV Types 
HPV1a,b,c; 
HPV2a-e; 
HPV3a,b; HPV4; 
HPV7; HPV10; HPV41 
HPV6a-f; HPV30; 
HPV11a,b; HPV40; 
HPV16 
HPV13; HPV32; HPV6a; 
HPV2; HPV11; HPV16 
HPVSa,b; HPV3a; 
HPV8; HPV9; HPV12; HPV10; 
HPV17a,b; HPV19-29 
HPV6a-f; HPV11a,b; 
HPV18; HPV16 
HPV16; HPV18; 
HPV31; HPV35 
HPV36; HPV39 
HPV33; HPV34; 
HPV37; HPV38 
Associated 
Lesions 
Skin warts 
Laryngeal warts 
Oral warts 
Epidermodysplasia 
Verruciformis <EV> 
Genital warts 
Cervical tumors 
Skin Lesions 
Small numbers of genital 
and skin carcinomas 
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Observed 
Malignant 
Conversion 
<in vivo) 
++ 
l 
+ 
+++ 
++ 
+++ 
Adapted from data cited by McCance <1986>, and Tooze <1981). 
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1. 2. 3 The Human Papillomaviruses 
Papillomaviruses were the first DNA tumor viruses to be 
discovered. They' are relatively small viruses containing a cir-
cular double-stranded DNA genome, approximately 8 kilobases in 
length. They have not been studied as extensively as the other 
members of the family Papovaviridae <namely the polyoma viruses 
and simian virus 40) largely due to the lack of a suitable cell 
~ul~ure system for virus propagation. 
Papillomaviruses are the aetiological agents of papillomas, or 
warts, in a wide range of animals including man. To date 41 dif-
ferent types of human papillomavirus CHPV) have been recognized 
and these are associated with a variety of lesions on many 
squamous epithelial surfaces <Table 4). Although usually benign, 
these squamous cell tumors can undergo malignant transformation. 
While both epidermodysplasia verruciformis CEV) and the cervical 
tumors exhibit a high rate of malignant transformation, genital 
and laryngeal papillomas have also been observed to undergo 
malignant transformation, but at lower frequencies. Factors that 
can influence the malignant transformation of the tumors include: 
the genetic make-up of the host; deficiency in the host's immune 
system; and co-carcinogens in the environment <Orth et al. 
1977).0nly certain papillomavirus types are involved in the 
development of malignant tumors, but the degree of involvement of 
the virus and the mechanism of this transformation to malignancy 
are unclear. 
The accepted systam of division of the genus into different. sub-
types is based on the identification of a new subtype as one that 
shows <50% DNA sequence homology <percentage cross-hybridization) 
with previously identified HPV's <McCance, 1986). 
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1.2.3.1 Association with malignant and pre-malignant diseases 
While some papillomavirus types ar~ associated with benign papil-
lomas, the DNA of other types can be identified in a high 
percentage of malignant tumors. This is particularly evident in 
carcinomas developing in EV patients, and for·genital cancer, and 
suggests a different oncogenic potential of the different HPV"s. 
1.2.3.1.1 Epidermodysplasia verruciformis <EV) 
EV is a very rare disease with lifelong persist~nce. The patients 
usually have congenital defects of cell-mediated immunity, and 
about one third of cases develop malignant carcinomas on an 
average of 24 years after the onset of the disea~e <Gissmann, 
1984). These carcinomas ·develop from flat skin warts, particularly 
at sun-exposed sites, suggesting UV Light as a co-factor in the 
de v e L o p me n t o f t h e d i s e a s e < G i s s m a n n , 1 9 8 4 ) . A l a r g e g r o up o f H P V 
types have been found associated with these Lesions, but only HPVS 
and HPV8 DNA has been demonstrated in carcinomas present in these 
patients <Smith et al., 1984). 
1.2.3.1.2 Genital and cervical cancer 
There is 
in the 
a growing body of evidence implicating papillomaviruses 
causation of human genital cancer <crawford, 1984). This 
evidence includes demonstrations that the majority of the tumor 
cells contain viral DNA. HPV16 is most frequently found occurring 
in about 60-90% of cervical cancers <McCance et al., 1986; Durst 
et al., 1983). Next most commonly found is HPV18, which is present 
in 15-36X of the tumors, as weLL as in cervical cancer ceLL Lines 
such as Hela, which has been extensively passaged in culture. 
However, this HPV type is absent from benign tumors and premalig-
nant Lesions <Boshart et al., 1984). HPV16 DNA is also found in a 
smaLL number of benign genital tumors, often in conjunction with 
the more usual HPV6 and 11 <Durst et al, 1983). It is isolated. at 
an increasing rate as the disease increases in severity, and is 
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also the type most frequently found in genital malignancies, other 
than cervical carcinoma <McCance, 1986; McCance et al., 1986>. 
It appears that integration of the viral DNA into the cellular 
genome is important in the _generation of genital cancer. In the 
majority of malignant Lesions such integration occurs, and eVen in 
commonly used cervical cancer cell Lines, such_as Hela, HPV18 DNA 
sequences are present in the form of defective integrated copies, 
and amplified to a high copy number (Schwarz et al., 1985>. In 
benign and premalignant Lesions, however, HPV DNA is found as free 
viral 
which 
nant 
monomers, often also in the p~esence of infectious virus 
cannot be produced in the undifferentiated cells of malig-
Lesions. While integration into the host chromosome has been 
shown to occur at severaL random sites, there does appear to be 
some specificity with regard to the break site in the viral genome 
<McCance, 1986>. This Leads to an interrupt~on of a region con-
taining the E1 and E2 early genes <Section 1.2.3.2). 
S i nee not aLL advanced stages of cervical intraepithelial 
neoplasia Lead to invasive disease, it is clear that other factors 
must be involved in the progressive disease. Zur Hausen <1982> has 
proposed that "initiating events" could interact synergisticaLLy 
with a promoting papi.Llomavirus infection and result in the trans-
formation of a premalignant Lesion to a malignant carcinoma. In 
analogy to UV-Light in EV patients, and chemical carcinogens in 
oesophageaL papiLLomatosis of catt-te <Section 1.2.3.1.4), these 
initiating events could be associated with herpes simplex virus 
infections, or smoking, in the case of genital cancer <Prakash et 
~L. I 1985). 
1.2.3.1 .3 Carcinomas of the Larynx and oraL cavity 
Carcinomas of the oral cavity are associated with HPV2, 11 and t6 
<McCance, 1986; de ViLLiers et al., 1985>. While carcinomas of the 
Larynx are associated with HPV16 and HPV30 <Brandsma et al., 1986; 
Kahn et al., 1986), HPV6 and 11 are also found in benign Laryngeal 
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papillomas CGissmann et al., 1983), which have been shown to 
convert to malignancy under the influence of X-radiation. 
1.2.3.1.4 Carcinoma of the alimentary canal in cattle 
The synergism between papillomavirus infections and other co-
carcinogens has been well-studied in various animal model systems. 
In SCotland papillomas of the alimentary canal of cattle, indticed 
by bovine papillomavirus 4, were shown to undergo a high rate of 
malignant transformation in animals feeding on bracken fern 
CGissmann, 1984). These papillomavirus induced lesions are common 
in the bovine oesophagus (Jarrett, 1973; Plowright, 1971), but in 
contrast to the situation observed with genital cancer, 
oesophageal cancer cells were not found to harbour viral DNA. This 
suggests that the presence of BPV-4 DNA is not required for the 
progression to, or the maintenance of the transformed state, but 
may be required for the initiation stage <Campo et al., 1~85). 
1.2.3.2 Genomic organiza~ion and transformation 
of papillomaviruses 
3~ I E41 
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The organization of early and late genes in three possible reading 
frames of the HPV6 genome C7.9kb). 
Adapted from McCance <1986). 
The viral genomes of 6 human papillomavirus types, HPV1~, HPV6, 
HPV16, HPV8 and HPV11, as well as bovine papillomavirus type 1 
<BPV1) have been completely sequenced <McCance, 1986). The or-
ganization of the genomes is well conserved between these types 
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and has a number of open reading frames encoding both early and 
late proteins (Figure 12). 
The difficulty in replicating HPV DNA in vitro has severely 
hindered the study of mechanisms of transformation by this virus. 
However, mouse cell transformation with cloned HPV DNA has been 
reported <Watts et al., 1984; Yasumoto et al., 1986) and more 
recently the transformation of heterografted human skin tissue by 
infection with HPV11 was demonstrated <Kreider et al., 1986>. This 
should facilitate the future study of factors permitting the 
neoplastic progression of HPV-induced Lesions in human tissues. 
BPV-type 1 is not subjected to the same in vitro growth restri~-
tions seen with HPV DNA, sjnce it is maintained as a stable 
plasmid in transformed fibroblasts. The E2 gene of this virus 
participates in gene control and has been shown to be inactivated 
when BPV1 transforms cells to the cancerous state <Marx, 1986). 
Furthermore, recent studies have identified the existence of a. 
transcriptional enhanc~r element in the non-coding region of the 
viral genome, which is transactivated by the E2 gene product, and 
may control the efficiency of replication and transformation 
(McCance, 1986). The bovine E2 gene is in a reaion that may be 
analogous to that disrupted by integration of the HPV DNA <Marx, 
1986). This integration has shown a remarkable specificity for 
opening circul~r, viral DNA within the E1-E2 open reading frames 
<Schwarz et al., 1985). A recent analysis of HPV16 integration in 
a cervical carcinoma has demonstrated the deletion of the entire 
E2 gene and the 
1986). Similarities 
greater part of the E1 gene CMatsukura et al., 
between the HPV E1 gene product and the 
polyoma virus Large T antigen, a product necessary for the initia-
tion of viral DNA replication, have revealed a possible role for 
the E1 protein in the control of eukaryotic DNA replication 
CCLertant et al., 1984). 
The HPV E6-E7 open reading frames are specifically transcribed. in 
cervical cancer cell Lines <Schwarz et al., 1985), and although no 
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protein product has, as yet, _been identified, it is significant 
that a corresponding region in BPV1 DNA has transforming potential 
(Schiller et al., 1984; Schiller et al., 1986). Based on recent 
studies of E6 and E7 gene expression in the HPV18 containing Hela 
cell Line, zur Hausen <1986) has proposed a model whe~eby the 
development of. human cancer is viewed as a failure of host-cell 
control of persisting viral genes. A celtular interfering factor, 
or CIF, is thought to negatively control HPV expression in in-
fected cells. During cell differentiation, however, these genes 
are switched off permitting the transcription and replication of 
viral DNA. This would explain the difficulty in repli~ating HPV 
DNA in vitro in terms of the dependence of viral replication on 
certain stages in squamous epithelial cell differentiation. A 
similar interruption in this cell-mediated control could be 
brought about by the action of synergistic co-factors. This could 
involve either the modification of the persisting viral genome 
such that it does not respond to CIF control, or alternatively a 
modification of the CIF genes, or CIF activating genes, to result 
iA a non-functioning CIF. This model provides .a ready explanation 
for the Long latency periods between primary infection and tumor 
appearance, observed in many virus-associated human cancers. 
1.2.3.3 Human papillomavirus infection and oesophageal carcinoma 
Morphological evidence of papillomavirus infection of the 
oesophagus has recently been published <Winkler et al., 1985; 
Hille et al., 1985; Hille et al., 1986; Syrjanen, 1982). Isaacson 
and co-workers observed histological changes indicative of such an 
infection in 8 out of 24 biopsy specimens from South African 
patients with carcinoma of the oesophagus <Hille et al., 1985> and 
in a further study in 23 of a total of seventy specimens <33X) 
<Hille et al., 1986). Syrjanen has reported similar changes in 24 
out of 60 carcinomas studied in Finland <40%) CSyrjanen, 1982). 
Further evidence has been provided by immunohistochemical studies: 
HPV antigens have recently been demonstrated in oesophageal biopsy 
spe~imens showing morphological changes indicative of HPV 
\ 
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·infection. Hille et al (1986) have shown 7 of a total of 23 (30X> 
.tumor specimens to be positive for HPV antigens by an im-
\ munoperoxidase technique. In a similar study Winkler et al <1985) 
showed 31X of the tumors to be positive· fDr· HPV antigen. 
Morris and Price <1986) have recently described a hypothesis 
Linking the concept of mucosal immune surveillance with the above 
morphological evidence, .in a sequence of events leading to 
squamous dysplasia and Jnvasive carcinoma. They suggest that in 
the presence of inadequate vitamin nutrition as well as heavy or 
recurrent virus exposure <which is common in close living 
conditions> certain cells of the immune system, responsible for 
the detection and erradication,of exogenous antigenic material, 
are functionally overwhelmed. This would facilitate the localized 
colonization of the oesophageal mucosa and tre development of HPV-
induced flat warts. Further progression of the disease could occur 
under the influence of p~rsistent infection with a particularly 
oncogenic HPV subtype, nutritional deficiency and additional 
initiating co-factors, such as aflatoxin and alcohol. This could 
• 
finally lead to the development of invasive carcinoma in a multi-
step sequence of events .. The hypothesis explains both the regional 
variation in the incidence of oesophageal carcinoma, and the sharp 
rise in the fncidence of the disease in the black population of 
South Africa. On the basis of this model, the presence of persist-
ing viral genes would not be essential for the maintenance of the 
malignant phenotype, only for it•s initiation. 
Histology and immunoperoxidase methods alone are not entirely 
conclusive of HPV infection, and absolute confirmation through 
electron microscopy and. molecular hybridization techniques is 
required~ To date there has only been one report of the detection 
of HPV DNA in oesophageal carcinoma tissue (Kulski et al., 1986). 
Five out of a 'total of 10 specimens analyzed by hybridization to a 
mixed probe of HPV types 11, 13, 16 and 18 were found to be 
positive. Since these HPV-positive oesophageal carcinomas were 
identified in Western Australia, a low risk area, there is now an 
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urgent need to examine oesophageal carcinoma cell Lines and biopsy 
specimens from high risk areas in South Africa for evidence of HPV 
DNA, and further to elucidate the possible role of this DNA tumor 
virus in the aetiology of oesophageal carcinoma. 
1.3 AIM OF THIS WORK 
Dr. K. Robinson, at the University of Natal <Durban) established 
10 continuous oesophageal carcinoma cell Lines, from oesophageal 
tumors of varying differentiation. In vitro and in vivo studies of 
these tumors have revealed that properties such as the degree of 
malignancy of the source tumors ·could be well correlated with 
their ability to become successfully established and to grow tor 
Lengthy periods in vitro. However, there was Little correlation 
between tumor differentiation and in vitro potential <Robinson, 
1981). 
In order to investigate the possible role of a viral co-factor in 
the aetiology of oesophageal carcinoma, I have screened three of 
these oesophageal cell Lines by DNA/DNA hybridization, for the 
-presence of stable, integrated viral sequences. The three cell 
Lines analyzed were HCU18, HCU39 and HCU33: HCU18 was grown from a 
poorly differentiated tumor specimen, HCU39 from a moderately 
differentiated tumor, and HCU33 from a well diffirentiated tumor. 
Cellular DNA was screened for evidence of the following human DNA 
tumor viruses: papillomaviruses (types 1,5,6,8,11,16,18), 
adenoviruses <species 5,7,12,31) and Epstein-Barr virus, as well 
as for the RNA virus, human T-Lymphotropic virus, HTLV-I. 
The human papillomaviruses would appear to be the most Likely of 
the different viral candidates, since there has been much recent 
evidence of papillomavirus infection of the human oesophagus both 
from morphological and from immunohistochemical studies <Section 
1 . 2 . 3 . 3 ) . 
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Although Epstein-Barr virus is traditionally regarded as a B-cell 
lymphotropic agent, evidence now indicates that this virus can 
also infect epithelial cells <Section 1.2.2.4). Similarly, while 
HTLV-I is strictly a T-lymphotropic agent, it has been sho~n that 
T-lymphocytes can infiltrate tissue such as the liver and the 
oesophagus, especially as a consequence of papillomavirus infec-
tion <Campbell, 1987, personal communication). 
The human adenoviruses have not been associated with any known 
\ 
human 
cause 
cancer. They are, nevertheless, oncogenic, and naturally 
severe infections of the respiratory and gastrointestinal 
tract in ~umans, and were therefore also included in this survey. 
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2. MATERIALS AND METHODS 
2.1 ORIGIN OF CELL LINES AND PLASMID PROBES 
The three oesophageal tumor cell Lines, HCU18, HCU33 and HCU39, 
established in culture by Dr. K. Robinson, were provided by Dr. C~ 
Albrecht. 
Human papillomavirus probes were provided by Dr. Campo CG(asgow> 
and Dr. E.M. de Villiers <Heidelberg). Epstein-Barr virus probes 
were provided by Dr. B. Griffin <London), and adenovirus probes by 
Dr. J. Bos CLeiden). An HTLV-I probe was provided by Dr. S. 
Josephs <Bethesda). Virus positive and negative control DNA was 
provided by colleagues of Dr. M. Renan at the Institute of Cancer 
Research, London. These control DNA's were: HPB-ALL, <acute Lym-
phocytic Leukemia, non-viral; negative control), Namalwa C.Burkitfs 
Lymphoma B-cell Line, with integrated EBV genome; positive con-
trol) and C91/PL Can HTLV-I producer T-cell Line; positive 
control). The positive control cell lines, Raji <Burkitt's Lym-
pho~a B-cell line, containing multiple copies of the EBV genome), 
and HeLa Cceryical carcinoma cell Line, containing multiple copies 
of HPV18), are routinely maintained in our tissue culture 
Laboratory. The human embryo fibroblast strains, HF1/81 and 4/81, 
were established in this Laboratory, and were used as negative 
controls. 
2.2 TRANSMISSION ELECTRON MICROSCOPY <TEM) 
2.2.1 Preparation of cell cultures tor embedding in resin 
The reagents used in the preparati~n of cell cultures tor TEM are 
Listed in Appendix I. 
Cell 
grown 
cultures of oesophageal tumor Lines HCU18, HCU33 and HCU39~ 
in 7Scm2 Falcon tissue culture flasks, were harvested for 
electron microscopy when the cell monolayers reached confluence. 
The monolayers were washed with physiological saline, and sub-
sequently with 0.1M -sodium phosphate buffer CpH 7.2). They were 
removed from the flasks by mechanical scraping, using a glass rod 
with rubber attachment. This serves to avoid the possible damaging 
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effects of trypsin on the cells. After resuspensi~n in a-10ml of 
0.1M sodium phosphate buffer, the cells were centrifuged to a 
pellet <1 500 rpm for 10 mins), and further resuspended in 8-10ml 
of 3% (v/v) gluteraldehyde. Cells were fixed in this solution by 
incubation at 4° for 30 mins. Thereafter the gluteraldehyde was 
removed by centrifugation (1500 rpm for 10 mins) and subsequent 
washing of the pellets in 0.1M sodium phosphate buffer <30 mins at 
4°C>. After two further 30 minute washes the cells were incubated 
in t.he same buffer at 4° overnight. The suspended cells were then 
pelleted by centrifugation at 4000 rpm for 20 mins, and the intact 
pellet retrieved and post-fixed for 1 hour in a 1% ~~4 solution . .. .. · 
<Palades fixative). Tissue blocks were washed three times <for two 
mins each) in sterile distilled water and subsequently stained in 
2% uranyl acetate for 15 mins at room temperature. Excess stain 
was removed by 3 furth~r 2 minute washes. Specimens were then 
dehydrated by incubation in ethanol, as follows: 
10 mins in a 60% solution of ethanol 
10 mins in a 80% solution of ethanol 
- 3 times, for 10 mins each, in absolute ethanol. 
2.2.2 Embedding and trimming of tissue blocks 
After fixation and dehydration the tissue blocks were embedded in 
L.R. White acrylic resin. The final dehydrating solution of 
ethanol was discarded and the resin added, and allowed to stand at. 
room temperature for 1 hour. To remove any remaining alcohol, the 
resin was replaced with fresh embedding medium, and Left to stand 
for a further hour at room temperature. This Last step was 
repeated once, after which tissue blocks were removed, and cut, 
using a sharp blade, into blocks of 0.5-1.0mm dimensions. Blocks 
were placed inside 
Polymerization was 
60°C overnight, and 
Beem capsules, which were filled with resin. 
carried out in an atmosphere of nitrogen at 
the tissue blocks were subsequently trimmed 
under a binocular dissecting microscope <Olympus). 
2.Z.3 Preparation of thin sections 
Glass knives prepared using an LKB knifemaker and 6mm thick plate 
glass <Plate Glass, Cape Town>, were carefully examined for any 
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defects, prior to use. A waterbath was attached to the knife with 
w~terproof pressure tape, and sealed at its base with Ernest 
Fullum boatsealer. 
Ultrathin sections were cut from the embedded tissue blocks by 
using a Sorval model MT-2 ultramicrotome. The thickness of the 
sections produced were judged from the interference colours shown 
by the sections floating in the waterbath <Peachey, 1958). 
Sections of 60-90nm, and silver in colour, were selected and 
transferred to 300 mesh 3mm diameter copper grids for staining and 
subsequent examination by electron microscopy. 
2.2.4 Staining and examination of thin sections 
A single drop of 2% uranyl acetate, and 0.2% Lead citrate were 
placed separately on parafilm on the bottom of a petri dish. Gri~s. 
were placed, with the sections downwards, on the uranyl acetate 
for 2 mins, and subsequently on the lead citrate for 2 mins. The 
grids were washed with sterile distilled water after each stain, 
and were finally placed on filter paper to dry. 
Stained specimens were examined in a Siemens Elmiskop 1A e(ectron 
microscope, at 60kV. 
2.3 PLASMID PREPARATION AND PURIFICATION 
2.3.1 Bacterial transformation 
Purified recombinant bacterial plasmids were initially used to 
transform recipient bacteria for the purpose of subsequent 
amplification and isolation of plasmid DNA. Competent E.coli HB101 
-cells were prepared by calcium chloride pretreatment (Maniatis et 
al., pg.250). Bacterial cell transformation was carried out as 
described in Part I, Section 2.6.4. Ampicillin resistant transfor-
mants were selected by plating on Luria agar plates containing 
50~~/ml ampicillin. 
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2.3.2 Preparation of stock cultures of recombinant plasmids 
Overnight 10ml cultures of E.coli HB101, carrying specific recom-
binant plasmids, and grown from a single ampicillin resi·stant 
transformant, were used to inoculate Luria agar plates <containing 
50 t-tg I m l amp i c i l l i n ) . A f t e r g r ow t h f o r 1 6-1 8 h our s a t 3 7 ° C , p l a t e s 
0 
could be stored at 4 C, and viable bacteria re~overed for Up to a 
month after inoculation. Long-term storage of selected strains was 
achieved by 1ncubation at -70°C in 15% glycerol <Part I, Section 
2.7). 
2.3.3 Amplification and isolation of. plasmid DNA 
E.coli HB101-derived strains carrying recombinant plasmids were 
inoculated from stock cultures into 10ml LB medium, containing 
50t-tg/ml ampicillin. Amplification, and subsequent isolation of 
plasmid DNA, was generally achieved according to the procedure 
described in Part I, Section 2.8.1. However, this "alkaline lysis" 
method is only efficient for the isolation of small plasmids, less 
than 10kb in length. Therefore certain of the signifcantly larger 
plasmids were more efficiently isolated by using an alternative 
"cleared lysate" method, as follows: 
The 10ml overnight culture was inoculated into 300ml of pre-warmed 
LB medium <containing 50 t-tg/ml ampicillin). This culture was 
shaking vigorously, for 12-16 hours. incubated at 37°C, 
Bacterial 
0 4 C) were 
cells, harvested by centrifugation <6000 rpm~ 10 min., 
resuspended in 5.2ml of 25% sucrose in 0.05M Tris 
CpH8.0). A 0.8ml volume of freshly prepared Lysozyme solution 
<20mg/ml in 0.25M EDTA, pH8.0) was added to the cell suspension, 
and the mjxture was swirled on ice for 5 mins. After the addition 
of 5.2ml of 0.25M EDTA <pH8.0), swirling was continued on ice for 
a further 5 mins. An 8ml volume of Brij/DOC solution <1% Brij 58, 
0.4% sodium deoxycholate in 0.01M Tris, 0.001M EDTA, pH8.0) was 
then added by rapid expulsion from a 10ml pipette, mixed, and left 
on ice for 20-30 mins. During this period the cells lysed to form 
a viscous mass. The cell debris and much of the chromosomal DNA 
was subsequently pelleted by centrifugation, at 15 000 rpm for 45 
mins at 4°C. The resultant straw-coloured supernatant was then 
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decanted, and prepared for centrifugation in a CsCL density 
gradient, as described in Part I, Section 2.8.1. 
2.4 ISOLATION OF VIRAL SEQUENCES FROM 
RECOMBINANT BACTERIAL PLASMIDS 
2.4.1 Isolation by electrophoresis onto DEAE-cellulose paper 
Cloned viral DNA inserts were excised from recombinant bacterial 
plasmids prior to radioisotope Labelling. This precluded spurious 
hybridization of vector DNA sequences to any plasmid DNA which 
might have contaminated the human DNA samples. The method used, a 
modification of that described by Dretzen et al. <1981), is 
described in Part I, Section 2.8.2. 
2.4.2 Extraction from Low-melting temperature <1mt) agarose 
Most grades of agarose are contaminated with sulfated polysac-
charides, which are potent inhibitors of many of the commonly used 
enzymes. Since these are extracted from the gel together with the 
DNA, they can cause problems in subsequent cloning reactions. 
Therefore, to isolate a particular Ad7c1 DNA restriction fragment 
for cloning into. pUC19, a highly purified Low-melting temperature 
agarose <Sea Plaque from FMC Bioproducts) was used. Digested DNA 
was separated by agarose gel electrophoresis <in 0.8% 1mt agarose 
in TAE, pH8.0) and the required restriction fragment eluted from 
the gel, according to the method described by Maniatis et al. 
(1982, pg.170)~ 
2.5 ISOLATION OF TOTAL HUMAN DNA FROM CELL LINES GROWN IN CULTURE 
Cell cultures, grown in sterile 75cm
2 tissue culture flasks were 
harvested for DNA extraction when the cell monolayers reached 
confluence. The cells were washed twice with 4-5ml of sterile 
physiological saline and then detached by trypsinization. The 
resultant cell suspe~sion was pelleted, at 1 500 rpm for 5 mins, 
washed a further 2 times with physiological saline, and pelleted 
<1 500 rpm, 5 mins>. Cells were resuspended in 10ml of 0.1M Tris, 
0.1M EDTA <pH8.0), and a 0.1ml aliquot counted using a 
haemocytometer <Bausch and Lamb). The concentration of cells was 
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then determined, and adjusted with 0.1M Tris, 0.1M EDTA Cph8;0) to 
6 
a final value of <2-4> x 10 cells/ml. Proteinase K was added at 
100~~/ml, and SDS at a concentration of 2%. The suspension was 
mixed gently for 5 mins at room temperature, and then incubated at 
56°C tor 1 hour. Two phenol extractions, using a~ equal volume of 
Tris-equilibrated 
organic phases 
mins. After 4 
phenol, were carried out, and the aqueous and 
separated by centrifugation at 3 000 rpm for 10 
further extractions, twice with phenol/chloroform 
<1:1) and twice with chloroform, the nucleic acid was precipitated 
from the aqueous phase by the addition of 2 volumes of ice-cold 
absolute ethanol <in the presence of 300mM NaAc) and incubati~n at 
-20°C overnight. Cellular DNA was then pelleted by centrifugation 
at 4 000 rpm for 15 mins, washed in 70% ethanol, and-pelleted 
again <4 000 rpm., 15 mins>. The DNA p~~let was dried under vacuum 
and ,re-dissolved in one fifth ~t the original volume of TE buffer 
CpH8.0). The resultant suspension was digested with heat-treated 
0 RNase (100~~/ml) by incuba~ion at 56 C for 2-3 hours. After 4 
further extractions with phenol C2x>, phenol/chloroform <1x>-and 
chloroform C1x), DNA was again precipitated by the addition ~f 2 
volumes of ice-cold absolute ethanol Cin the presence of 
300 mM NaAc> and incub~tion at -20°C overnight Cor alternatively 
0 
at -70 C tor 1 hou~). The purified cellular DNA, recovered by 
centrifugation at 4 000 rpm tor 15 mins, was washed in 70% ethanol 
to remove any remaining salt. It was then dried under a vacuum and 
redissolved in one-ten~h of the original volume of sterile dis-
tilled water, by gentle mixing and incubation at 4°C overnight: 
The final DNA concentration was determined by comparison with 
known concentrations of ~-phage DNA following 
electrophoresis and ethidium bromide staining of 
described in Part I, Section 2.4. The yield of pure 
from 1 x 10 8 cells ranged from 200 to 400~~- The DNA 
~tored at 4°C until further use. 
agarose gel 
the DNA, as 
DNA isolated 
samples were 
2.6 RESTRICTION ENDONUCLEASE DIGESTION AND AGAROSE GEL 
ELECTROPHORESIS OF TOTAL HUMAN DNA 
Twenty micrograms of_ DNA, extracted from established human cell 
lines, was digested with 60 units of restriction endonuclease 
<Boehringer-Mannheim or Amersham) in the presence of the ap-
propriate enzyme buffer. Final digestion volumes were made up to a 
total of ZOO~L with sterile, distilled water. Incubation was 
carried out at 37°C for 12-16 hours in order to ensure that di-
gestion was 
the samples 
addition of 
300mM NaAc) 
Precipitated 
ethanol and 
complete. Reactions were then terminated by heating· 
at 65°C for 5 mins. The DNA was precipitated by the 
2 volumes of absolute ethanol <in the presence of 
and subsequent incubation -at -70°C for 1 hour. 
DNA was recovered by centrifugation, washed in 70% 
dried under vacuum. It was then re-dissolved in 50ML 
of sterile distilled water. 
Prior to the final separation of restriction fragment~, 3~ll ali-
quots of each sample were analyzed by electrophoresis in 0.8X 
agarose Cin TAE, pH8.0), initially to ensure that the digestion 
had been complete, and subsequently to adjust all of the samples 
to the same DNA concentration. Aliquots of ea~h sample, containing 
10~~ of DNA, were then made up to a final v~Lume of 40ML with 
sterile distilled water, and 4~~ of Loading buffer <0.25% w/v 
bromophenol blue, 0.25% w/v xylene cyanol, 15% w/v Ficoll). 
Electrophoresis was performed in 0.8% agarose gels <in TAE, pH8.0) 
at 40V <2V/cm) for 16-18 hours. 
When electrophoresis was complete, the gels were stained in a 
solution of 500~~/ml ethidium bromide Cin TAE buffer>, viewed by 
UV transillumination, and photographed. Prior to transfer of the 
separated DNA restriction fra~ments onto Hybond-N nylon membranes, 
the DNA was denatured and neutralized in situ, as described in 
Part I, Section 2.4. 
2.7 TRANSFER OF DNA TO NYLON MEMBRANES 
Cellular DNA, which had been digested and separated by 
electrophoresis, was transferred onto nylon membrane according to 
a modification of the method of Southern (1975), as described in 
Part I, Section 2.5. Alternatively, total, undigested DNA was 
spotted onto the nylon membrane, as follows: 
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Aliquots of sterile, distilled water containing 0.5, 1.0, 2.0 and 
4.0 t·-'-9 of cultured oesophageal tumor cell DNA, and similar ali-
quots, containing positive and negative DNA's, were filtered 
through a Hybond-N-membrane, using a Bio-Rad Dot-Blot apparatus. 
Recombinant bacterial plasmid DNA (10-80 pg) was also filtered 
onto the m€mbrane as positive controls. The membrane was pre~etted 
in 20X sse prior to filtration. Excess sse was blotted off onto 
sterile 3MM filter paper CWhatman). After filtration was complete 
the membrane was removed from the apparatus and placed DNA-side 
downwards on a piece of 3MM filter paper, saturated with denatur-
ing s~lution C1.5M Nael; O.SM NaOH) for 5 mins. It was then 
transferred to a second piece of filter paper, saturated with 
neutralizing solution <3M NaAc, pH5.2) for a further 5 ~ins. After 
air-drying the membrane the DNA was covalently bound to its sur-
f~ce by UV-illumination C300nm) for 2-5 mins. 
2.8 HYBiiDIZATION OF 32 P-LABELLED PROBES TO DNA BOUND TO 
NYLON MEMBRANES 
2.8.1 Southern blot hybridization 
Prehybridization and hybridization was carried out in the presence 
of Denhardts solution, and denatured, sonicated salmon sperm DNA. 
Denhardts solution was prepared as a SOX concentrated stock con-
taining 1% w/v Ficoll, 1% w/v polyvinylpyrrolidone (type 360) and 
1% w/v bovine serum albumin fraction 5, dissolved in sterile 
distilled water. It was stored frozen, at -20°e, in Sml aliquots, 
and was thawed at 37°e prior to use. Both prehybridization and 
hybridization reactions were carried out in heat-sealed plastic 
bags, as described in Part I, Section 2.9. Viral DNA probes of 
high specific. activity ([5-15] x 107 dpm/t-.•.g DNA) were prepared by 
32 
nick translation in the presence of a. P dCTP <Part I, Section 
2.8.3). 
The membranes were prehybridized with a 10ml solution containing 
5X sse, 50mM Na 2Po 4 , 5X Denhardts solution, 50t-.~/ml denatured, 
sonicated salmon sperm DNA, and 50% deionised formamide, for 2-4 
hours at 42°e. Hybridization of radiolabelled single-stranded 
probe DNA was performed in a further 10ml solution, containing 
3xsse, 20mM Na 2Po 4 , 1X Denhardts solution, SOt-.~/ml denatured 
salmon sperm DNA, 50% formamide and 10% w/v dextran sulphate. This 
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reaction was carried out at 42°C for 16-18 hours. Unhybridized 
probe DNA was removed by stringent washing of the membrane as 
follows: twice for 30 mins at room temperature with 2XSSC contain-
o ing 0.1% SDS, followed by two washes at 60 C for 30 mins each in 
0.1XSSC containing 0.1% SDS. The m~mbranes were then 
autoradiographed, with intensifying screens, on X-ray f i l m 
0 CXOmat MA, Kodak) for an average of 10 days at -70 C. 
Low stringency hybridization to HPV DNA was periormed as described 
above, but at a formamide concentration of 20%, and in the 
presence of 6XSSC <Tm-42°C). The membrane was washed 3 times in 
2XSSC with 0.1% SDS at room temperature, and for 1 hour at 50°C 
CT -40°C). After overnight autoradiography, the membrane was 
m 
washed twice at high stringency, in O.SXSSC plus 0.1% SDS, at 55°C 
0 for 1 hour CT -25 C), and autoradiographed for 1 day to 10 days. 
m / 
' 
The melting temperature, T , measures the thermal stability of DNA 
m 
hybrids, and is calculated as follows <Anderson and Young, 1986): 
T = 81.5 + 16.6 Clog Ml + 0.41 C%G+C) - 0.72 C% formamide) 
m 
<where M, the molarity of the monovalent cation, is 1 in a 6XSSC 
solution~ and % G+C is 41% for HPV DNA [Lancaster and Olson, 
1982]). 
Hybridizations should be carried out at an incubation temperature 
that is 20-25° below T , to achieve a maximum rate of DNA-DNA 
m 
annealing. Mismatching of DNA duplexes has the effect of lowering 
the 
by 
T . An increase 
m 
0 0.7 C for every 
in formamide concentration also lowers the T 
m 
1% increase in the concentration <Maniatis et 
a l . ~ 1982; pg.389). Thus, by holding the incubation temperature 
constant and lowering the formamide concentration, conditions can 
be optimised to detect mismatched duplexes. The stringency of the 
reaction 
and this 
sequences. 
can also 
should 
be altered by varying the salt concentration, 
be kept fairly high to detect mismatched 
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2.8.2 Dot blot hybridization 
Dot blot hybridization tests were carried out, in most cases, 
according to the procedure of Johnson et aL. (1984), as des~ribed 
in Part I, Section 2.9. This is a more simple method that usas an 
incubation cocktail, termed "BLOTTO", containing nonfat dry milk 
as a blocking agent Cin place of Denhardts solution and sheared 
salmon sperm DNA). Johnson et al. (1984) have demonstrated that 
thii procedure is 
analyses, and is 
mammalian genomes. 
as efficient as conventional Southern blot 
capable of detecting single copy sequences in 
The "BLOTTO" method was thus chosen as a more 
suitable alternative for the rapid analysis of a Large number of 
s amp L.es. 
2.9 REMOVAL OF PROBE AND RE-USE OF DNA BLOTS 
Hybond-N membranes which were to be used more than once were kept 
moist, wrapped in Saran Wrap, and stored at 4°C in.the dark. Probe 
DNA was removed frdm the membrane by incubation at 45°C in 0.4M 
NaOH for 30 mins, foLLowed by a further 30 minute incubation Cat 
45°C> in a solution containing 0.1XSSC, 0.1% SDS and 0.2M Tris 
CpH 7.5>. The membrane was then autoradiographed to ensure that 
removal of the probe had been successful. 
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3. RESULTS 
3.1 ULTRASTRUCTURAL ANALYSIS 
3.1.1 Introduction 
The 3 oesophageal carcinoma cell Lines HCU18, HCU33 and HCU39 were 
established in cul~ure during the period 1976-1980. Thes~. 
together with 7 others, initiaied during the same periodr have 
been extensively examined by electron microscopy <Robinson, 1981). 
Several features observed in certain of these cell Lines were 
suggestive of a possible viral involvement with carcinoma of the 
oesophagus. These included: 
1. Prominent 20-30nm intranuclear particles in 1 cell Line; 
2. Bundles of 8-14nm cytoplasmic rods in 4 cell -Lines including 
HCU18 and HCU33; 
3. Aggregates of electron dense 40nm cytoplasmic rods in 3 cell 
Lines, including HCU33; 
4. Well developed annulate Lamellae in 5 cell Lines including 
HCU18 and HCU33; 
5. Well developed rough endoplasmic reticulum and golgi 
complexes in several specimens <notably HCU18), suggestive 
of increased protein synthesis. 
Virus particles were not detected in the 3 cell Lines HCU18, HCU33 
and HCU39. A possible viral infection could, however, involve the 
persistence of viral DNA in the tumor cells without the production 
of virus particles. Latently infected cells could be non-
permissive of viral replication, or alternatively semi-permissive, 
inducing the production of virus at a Low frequency. Since the 
3 cell lines have been extensively passaged in tissue culture 
subsequent to these initial studies, the tumor cells could well 
have become altered both in genotype and phenotype during adapta-
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tion to an in vitro environment. These cell Lines were briefly re-
examined in this study for the possible presence of virus 
particles in the tumor cells. 
3.1.2 In Vitro Characteristics of Cell Lines 
HCU18, HCU33 and HCU39 
A coverslip culture of oesophageal tumor cells from Line, HCU18 is 
shown in Figure 
morphologically, 
13. Cells of the 3 Lines could be distinguished 
and their features corresponded to those 
originally described for these 3 cell Lines <Robinson, 1981). 
HCU33 cells varied in size and shape and were characterized by 
their rapid growth in tissue culture; HCU18 cells were angular in 
shape, while HCU39 cells appeared to be more rounded. Particularly 
Large cells containing 3-4 nuclei were also evident in all 3 cell 
Lines. It has been suggested that these giant cells could have 
arisen as a result of a virus-induced fusion process, <Robinson, 
1981). Cells of all 3 Lines were shown to exhibit a typical piling 
effect characteristic of tumor c~Lls grown in culture. 
FIGURE 13 
HCU18 cells stained with haematoxylin and eosin. 
The cells show a typical epithelial morphology. 
Magnification 60X. 
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3.1 .3 Transmission Electron Microscopy 
Electron micrographs of each of the 3 tumor cell Lines are shown 
in Figures 14, 1 5 , 16 and 17. Although the presence of obvious 
virus-Like structures could not be detected in any of the 3 cell 
Lines, several features that have been previously described 
<Robinson, 1981>, and that could be indicative of a viral associa-
tion with these cells, were observed in the present work! 
1. The extensive presence of rough endoplasmic reticulum was 
noted in HCU18 and HCU33 cells <Figures 14 and 15). This was 
occasionally dilated, and appeared to be particularly well 
developed in Line HCU18. 
2. Mitochondria and golgi bodies were apparent in all 3 Lines, 
and were particularly prominent in HCU18 cells (Figure 14). 
The mitochondria were round in shape with clearly defined 
cristae. 
3. Dense Lamellar structures, or myelinoid bodies were present 
in all 3 cell Lines. They were found in the cytoplasm of the 
tumor cells, and varied both in size and shape <Figure 16). 
Regular nuclei, with densely staining nucleoli, were also observed 
in all 3 cell Lines <Figures 15, 16). Numerous Lipid-containing 
vacuoles were characteristically present in the cytoplasm of HCU39 
cells <Figure 16). 
A particularly interesting feature of the HCU33 Line was the 
presence of regular arrays, observed frequently in the cytoplasm 
of these cells (Figure 17>. They were found in association with 
mitochondria, and were composed of a repeated subunit structure, 
approximately 50nm in diameter. Paracrystalline bodies have pre-
viously been observed in the cytoplasm of HCU33 cells, in close 
proximity to mitochondria. These consisted of parallel arrays of 
fine filaments which varied in diameter <Robinson, 1981). The 
subunit structures demonstrated in this study appeared to be 
hexagonal in shape, and bounded by a double-Layered membrane . 
Longitudinal filamentous structures were not observed. 
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FIGURE 14 
Transmission electron micrograph showing two adjacent cells of 
the HCU18 Line. The extensive presence of well developed rough 
endoplasmic reticulum <ER), with attached ribosomes, is evident. 
Numerous mitochondria (M) are also seen distributed within the 
cytoplasm, and a single nucleus (N) bounded by a double nuclear 
membrane, is present. 
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FIGURE 15 
Transmission electron micrograph showing the presence of well-
developed rough endoplasmic reticulum (ER) in the cytoplasm of an 
HCU33 cell. The nucleolus <Nc) is seen as an electron dense body, 
within the nucleus (N). 
FIGURE 16 
Transmission electron micrograph of an HCU39 cell. Electron dense 
Lamellar structures, or myelinoid bodies <My) are present; 
mitochondria (m) and numerous vacuoles, some containing Lipid <LV) 
are also evident. The Large nucleus (N) contains an electron dense 
nucleolus <Nc). 
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FIGURE 17 
Transmission electron micrograph of a regular array, in close 
proximity to mitochondria (M), in the cytoplasm of an HCU33 cell. 
The hexagonal subunit struct u re <SOnm in diameter), bounded by a 
double-Layered membrane, is clearly evident. 
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3.1.4 Conclusion 
The 3 o~sophageal tumor cell lines, HCU18, HCU33 and HCU39, were 
shown to retain many of the phenotypic characteristics originally 
described for these cells <Robinson, 1981). Examination by light 
microscopy revealed that the cells of each line could be distin-
guished morphologically, and several features, characteristic of 
the individual Lines, were observed by transmission electron 
microscopy. 
These studies did not reveal the presence of virus-like structures 
in the oesophageal tumor cells. However, several of the mor-
phological features observed could be associated with a viral 
activity in these cells, as follows: 
1. The prominent presence of rough endoplasmic reticulum in 
HCU18 and HCU33 cells could reflect an increase in cellular 
protein synthesis due to virus replication. 
2. Well-developed mitochondria and golgi bodies could also b• 
indicative of an increased energy requirement and transport 
activity induced by the presence of virus. 
3. The myelinoid-like bodies observed in the three tumor Lines 
have previously been described in virus infected cells (Miyai 
et al., 1963). 
Each of these features may alternatively be related to the rapid 
growth and differentiation of the tumor cells. 
Groups of hexagonal structures were observed in the cytoplasm of 
HCU33 cells. The regular subunit structure of these arrays sug-
gests that they may represent deranged viral capsid production. 
They could, alternatively, be an artifact of tissue culture, or be 
associated with abnormal protein metabolism. 
3.2 PREPARATION OF VIRAL DNA PROBES 
3.2.1 Introduction 
All recombinant plasmid probes were expanded in the E.coli HB101 
<or JM107> host strain, and purified in CsCl density gradients. 
The viral DNA inserts were subsequently excised by digestion with 
the appropriate restriction enzyme, and purified tor radiolabell-
ing and hybridization analysis <Section 3.3). A total of 18 
different plasmid probes were used <Table 5). These encoded viral 
DNA sequences from different segments of Epstein-Barr virus, human 
papillomavirus <types 1,5,6,8,11,16 and 18), human adenovirus 
<species 5,7,12 and 31), and human T-lymphotropic virus type 1. 
3.2.2 Human Papillomavirus 
Increasing evidence, as discussed in Section 1.2.3, points to a 
role for specific types of HPV in certain types of human cancer. 
Plasmid probes, developed from 7 different HPV types (HPV 
5~8,6,11,16,18 and 1) were used. Six of these have been identified 
at relatively high frequency, particularly in association with 
specific squamous cell carcinomas CHPV 5,8,16 and 18), or in 
association with les.ions that frequently convert to malignancy in 
vivo CHPV6 and 11). 
Since the HPV genome is only on average 7.8kb in Length, the 
entire sequence has been cloned in~o pBR322 for each of the dif-
ferent HPV types <Table 5). However, HPV5, HPV8 and HPV6 were all 
cloned as two separate fragments, and each of these fragments was 
used in this work as a separate radiolabelled HPV specific probe 
in hybridization tests. Viral DNA inserts released from pBR322 
sequences by cleavage with BamHI and/or EcoRI and subsequent 
electrophoresis in 1X agarose gels, are shown in Figure 18. Figure 
18A shows HPV1 recombinant plasmid, Figure 18B, the genital HPV 
I 
plasmids, and Figure 18C, the EV-associated HPV plasmids. The 
HPV18 DNA insert is cleaved by EcoRI and BamHI into 3 separate 
fragments, 4.2kb, 2.4kb and 1.1kb in Length. HPV11 has one 
internal EcoRI restriction site, and is cloned at the BamHI site 
of pBR322. For hybridization analysis, as for all other HPV's, the 
entire HPV 11 insert C7.7kb) was excised and radiolabelled. 
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TABLE 5 Recombinant Bacterial Plasmids & Associated Viral DNA Inserts 
Plasmid Vector Insert Source Reference 
Designation 
I pHPV 6Amp2 pBR322 5.4kb (BamHI/EcoRI) Dr.Campo (Glasgow) de Villiers et al.,l981 
PAPILLOMA- pHPV 6K21 pBR322 2.5kb (BamHI/EcoRI) Dr.Campo (Glasgow) de Villiers et al.,l981 
VIRUS pHPV 16 pBR322 7.2kb (BamHI/EcoRI) Dr.Campo (Glasgow) DUrst et al., 1983 
pHPV 18 pBR322 7.85kb(BamHI/EcoRI) Dr.Campo (Glasgow) Boshart et al., 1984 
pHPV 5/48 pBR322 1.9kb (!££RI) Dr.de Villiers (Heidelberg) Kremsdorf et al., 1982 
pHPV 5/9 pBR322 5.9kb (EcoRI) Dr.de Villiers (Heidelberg) Kremsdorf et al., 1982 
pHPV 8/4 · pBR322 5.7kb (BamHI/!££RI) Dr.de Villiers (Heidelberg) Pfister et al, 1981 
pHPV 8/3 pBR322 2.0kb (~HI/EcoRI) Dr.de Villiers (Heidelberg) Pfister etal., 1981 
pHPV 11 pBR322(L47)a 7.7kb (~HI) Dr.Campo (Glasgow) Gissman et al., 1982 
pHPV 1 pBR322 7.7kb (~HI) Dr.Burnett (Birmingham) Heilman et al., 1980 
II pBamHIF pBR322 7.4kb (~HI) Dr.Griffin (London) Arrand et al., 1981 
EPSTEIN- pBAMHIW pBR322 3.07kb(BamHI) Dr.Griffin (London) Arrand et al., 1981 
BARR VIRUS pEcoRIC Homer! 17.17kb(EcoRI) Dr.Griffin (London) Arrand et al., 1981 
III pAdl2RIC pAT153 5.5kb (!££RI) Dr. Bos (Leiden) Bos et al., 1981 
ADENOVIRUS pAd31 pAT153 5kb (~HI) Dr. Bos (Leiden) Bos, pers. communic. 
pAd5XhoiC 
b 
pAT153 5.7lkb(!££RI/Hindiii) Dr. Bos (Leiden) Bernards et al., 1982 
pAd7clHindJ pUC19 1. 3 4kb (Hindi II ) --- ---
IV pMT2 pUC12 8.5kb (Sac!) Dr.Josephs (Bethesda) Josephs, personal 
HTLV-I communication. 
a. HPVll was first cloned into lambda phage (L47), and subsequently into pBR322. (Gissman ~., 1982a). 
b. The.complete 5.7lkb Ad5 insert cannot be excised from pAdS !h£IC; the 3kb !££RI/Hindiii fragment was used as a 
probe (Section 3.2.4.3). 
co 
..... 
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FIGURE 18 
Human papillomavirus recombinant plasmid probes. Viral DNA se-
quences were released from p8R322 vector DNA by cleavage with 
8amHI and/or EcoRI <as indicated in Table 5 [pHPV11 . is digested 
with 8amHI and EcoRil>, and separated by electrophoresis in 1r. 
agarose. Figure 18A shows pHPV1 <Lane 2>, Figure 188, the genital 
HPV's (pHPV11, lane 2; pHPV6K21, lane 3; pHPV6Amp2, lane 4; 
pHPV18, Lane 5; pHPV16, Lane 6), and Figure 18C the EV-associated 
HPV's (pHPV5/9, lane 2; pHPV5V48, lane 3; pHPV8/3, lane 4; 
pHPV8/4, Lane 5) ~ DNA, digested with Hindi!! is indicated in Lane 
1 of each Figure <and Lane 7 of 188). 
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3.2.3 Epstein-Barr Virus 
0 10 20 30 40 50 60 70 80 90 100 110 120 130 140 150 160 170 180 kb 
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FIGURE 19 
Restriction endonuclease cleavage maps <BamHI, EcoR!) of the 895-8 
strain of EBV DNA. The BamHI and EcoRI restriction fragments, used 
as radiolabelled probes, are indicated <Bamw, BamF, EcoRIC>. 
Regions p65, p5 and p31 represent viral sequences encoding puta-
tive B-lymphocyte (p65,p5), and epithelial cell <p31) 
immortalizing proteins. 
Three EBV viral 
and EcoRI 
probes were 
C <EeoC) 
used: the BamHI W <BamW), BamHI F 
restriction fragments of the EBV 
genome. The genome of Epstein-Barr virus is composed of unique DNA 
interspersed with repetitive DNA sequences. The 3.1kb large 
internal repeat, or BamHIW repeat, occurs approximately 11 times 
in the 895-8 isolate of Epstein-Barr virion DNA <Arrand et al., 
1981). This fragment, and the 7.4kb BamHI F fragment of the 895-8 
EBV strain have been cloned in pBR322 at the BamHI restriction 
site <Arrand et al., 1981). The significantly larger 17.2kb EcoRI 
C fragment of EBV 895-8, has been cloned into the cosmid vector, 
Homer I <Arrand et al., 1981). The relative positions of these 
3 fragments on the restriction enzyme cleavage map of EBV 895-8 
are shown in Figure 19 . The 3 clones designated p65, p5 and p31 
represent EBV DNA sequences that have been cloned, and analyzed 
for their ability to transform cells in vitro <Griffin and Karran, 
1984). While p5, which encompasses BamF and BamW DNA sequences, is 
immortalizing for a-Lymphocytes <Griffin, personal communication) 
neither this clone nor the p65 clone will immortalize epithelial 
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cells in vitro. However, the clone designated p31, which includes 
the sequence encoded by EcoRI fragment C, was found to transform 
both monkey and human epithelial cells in vitro <Griffin and 
Karran, 1984). 
Furthermore, the transforming region of p31 does not overlap with 
any of the 4 regions <LT1 ~ LT4) which a~e expressed in EBV immor-
talized B Lymphocytes <Section 1.2.2.3). The protein encodad by 
LT1 (map position 13 ~ SOkb) is specifically regarded as essential 
for EBV induced cell transformation <Kieff et al, 1982). 
3.2.4 Human Adenovirus 
3.2.4.1 Subgenus A probes 
Recombinant plasmid probes from 2 of the members of highly 
oncogenic subgenus A, Ad12 and Ad31, were provided by Dr. H. Bos 
<Leiden>. Each of these plasmids encodes sequences from the entire 
E1 transforming region of the different adenovirus strains. Ad12 
and Ad31 DNA inserts, used as Labelled specific probes in this 
work, are shown in Figure 20A <Lanes 2 and 3, respectively), 
separated from their pAT153 vector sequences by electrophoresis in 
1X agarose. 
3.2.4.2 Subgenus B probe 
No probes were available to us to analyze the oesophageal tumor 
cells for the presence of integrated copies of the weakly 
oncogenic <subgenus B) adenoviruses, such as Ad?. A Laboratory 
isolate of Ad? <Nr2203) was therefore used as the source of a 
specific DNA probe. This strain, isolated from a patient with 
post measles pneumonia, at the Red Cross Childrens· Hospital (Cape 
Town), has been designated as an Ad7c1 genome type <refer to Part 
I ) . 
The transforming genes of Ad? reside in the <5") Leftmost 7.8Y. of 
the viral genome, within the early region E1 <Fujinaga et al., 
1984>. This region is represented by the Hindiii I.J restriction 
fragments. In this work the 1.34kb Hindiii J fragment was cloned 
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into the plasmid vector pUC19 at the Hindiii restriction site, and 
subsequently amplified for use as an Ad? specific probe. This 
Hindiii J fragment encodes a short segment of the E1A region and a 
Large portion of E18 <refer to Figure 10). It was regarded to be 
suitable for use as a probe since the expression of both the E1A 
and the E18 genes is required for the oncogenicity of Ad?. 
A· 1 2 3 4 5 B 1 2 
-
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-
FIGURE 20 
Human adenovirus recombinant plasmid probes. 
A: Ad12, Ad31 <subgenus A) and AdS <subgenus C) recombinant plas-
mids, analyzed by electrophoresis in 1r. agarose. 
Lane 1 = -;., Hindiii digest; 2 = pAd12RIC, EcoRI digest; 3 = pAd31, 
8amHI digest; 4 = pAd5XhoiC, EcoRI/Hindiii digest; 5 = pAdSXhoiC, 
Sa c! digest. 
8: Plasmid pAd7c1HindJ, digested with Hindiii and separated by 
electrophoresis in 1r. agarose <Lane 1). Lane 2 shows a Hindiii 
digest of Ad?-2203 <subgenus 8); fragment sizes <kb) in decreasing 
order of molecular weight are: 7.53 (A), 5.97 (8), 4.85 (C), 4.56 
(D), 3.44 CE), 3.33 (F), 2.10 CG), 1.70 (H), 1.38 (!), 1.34 (J). 
The procedure used in this study for cloning the Ad7c1 Hindi!! J 
fragment into pUC19, was essentially as described in Part I, 
Section 2.6 for the cloning of Ad7c1 EcoRI D. However, in this 
case the Hindi!! J fragment was first purified from the remaining 
viral sequences prior to the Ligation of vector and insert DNA. 
This was done by electrophoretic separation and isolation in a Low 
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melting temperature agarose gel. Thirty-six recombinant bacterial 
clones were derived from the Ligation of 7S -100ng of insert DNA -
Ad7c1 Hindiii J fragment - and an equimolar quantity of pUC19 DNA 
~50-200ng). Twelve of these clones were screened, and found to 
-harbour an fdentical plasmid C3.94kb) comprisini pUC19 DNA C2.6kb) 
and a 1.34kb Ad7c1 insert (Hindiii J fragment> cloned at the 
Hindiii restriction site <Figure 208). This plasmid, which we 
designate pAd7c1HindJ, was further amplified in E.c~Li JM107, and 
purified for use in subsequent hybridization tests. 
3.2.4.3 Subgenus c probe 
Sac I 
Hindm 
Sac I 
FIGURE 21 
pAd5XhoiC 
8-79 kb 
PAT153 
3·08kb 
IXhol/Saii) 
The AdS recombinant plasmid, pAdSXhoiC. The XhoiC fragment <0.08-
5.79kb> of AdS was cloned into the 3.08kb SaLI/Hindiii fragment of 
pAT153 <Bernards et al., 1982). Positions of restriction sites in 
the AdS genome are indicated (in kb) by the position of the site 
relative to the Left end of the viral DNA. 
T h e r e c om b i n a n t p L a s m i d , p A d 5 X h o I C , p r ov i de d b y D r . H . B o s 
CLeiden>, is shown in Figure 21. The XhoiC fragment of AdS, cloned 
into the plasmid vector pAT153, encodes the entire E1 region, 
which falls within the first 4 kilobases of the viral genome. The 
restriction· enzyme sites indicated in brackets represent cutting 
sites that were destroyed in the procedure used for cloning this 
fragment <Bernards et al., 1982). Digestion with Sali and Xhoi 
will yield cohesive termini that can be Ligated together, but form 
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a hybrid site -that is not recognized by either en
zyme. While 
incubation with the enzymes Sall and Xhol had no ef
fect on the 
intact plasmid, digestion with Hindlll served to Li
nearize the 
8.79kb plasmid <r~sults not shown>. This intact Hind
lll cutting 
site clearly represents that site at map position 
2.8kb on the 
viral genome. <and not at 0.08kb) since double digestion with ~I 
·and Hindlll gave rise to two fragments S.7kb and 3.0
kb in Length 
<Figure 20A, Lane 4>. The smaller of these EcoRI/Hi
ndlll frag-
ments essentially encodes the AdS Hindlll G restrictio
n fragment, 
which will transform cells in vitro <van der Eb an
d Bernards, 
1984), and a small 0.03kb overlap of pAT1S3 DNA. This sequence 
contains region E1A and about half of region E18, and 
was used in 
this study as a Lab~Lled specific AdS probe for hybri
dization to 
oesophageal tumor cell DNA. 
3.2.S Human T-Lymphotropic virus type I 
Although the retrovirus HTLV-1 is strictly regard
ed as a T-
Lymphotropic agent, T-Lymphocytes. have been reported to
 infiltrate 
oesophageal .tissue, especially as a consequence of pa
pillomavirus 
infection <Campbell, 1987,. personal communication). The pMT2 clone 
is a nearly' full Length provirus cloned into the plas
mid vector 
pUC12 at the Sacl restriction site. This complete s
equence was 
excised and used as a radiolabelled DNA probe, to s
creen the 3 
tumor Lines for integrated HTLV-1 DNA. 
3.3 HYBRIDIZATION ANALYSIS 
3.3.1 Introduction 
The 10 different HPV specific probes that were used were derived 
from 7 of the 41 HPV types that have thus far been identified. All 
of these probes were tested in dot blot hybridization ~ests, under 
conditions of high stringency. The human papillomaviruses are a 
remarkably heterogeneous group characterized by a Lack of nucleic 
acid homology - the DNA's of different types generaLLY show only a 
few percent cross-hybridization under stringent hybridization 
conditions (McCance, 1986). However, all of the HPV's identified 
to date will 
g·e n c y ( K a h n 
cross-hybridize under conditi~ns of reduced strin-
et al., 1986). It is this property that has 
facilitated the recent identification of new HPV types in tissue 
samples and cell lines (Kawashima et al., 1986; Lorincz et al., 
1986; Brandsma et al., 1986; Ostrow et al., 1987; Boshart et al., 
1984). By using high specific activity probes, developed from 
cloned HPV DNA, under conditions of reduced stringency, DNA from 
one HPV type can be used to detect another, allowing it in turn to 
be cloned and subsequently used at high stringency. Therefore, to 
detect the possible presence of a further, and possibly as yet 
unidentified HPV type, in the oesophageal tumor cell DNA, an HPV18 
probe was used in Southern blot hybridization tests u~der condi-
tions of reduced stringency. Both HPV18 and HPV16 are regarded as 
particularly oncogenic, and represent the only 2 HPV types whose 
viral DNA is frequently found integrated in the host cell genome 
in malignant tumors. Both types, but predominantly HPV18, are also 
found in an integrated state in cell Lines derived from cervical 
carcinomas <McCance, 1986). 
The 3 EBV probes that were used <BamW, BamF and EeoC) were derived 
from the B95-8 strain of EBV. Although EBV isolates from different 
populations have been found to differ, these strain differences 
are largely insignificant <Dambaugh et al., 1986). Therefore, each 
of the probes, tested under conditions of high stringency, should 
be specific for any particular EBV. isolate that may be present. 
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Within the human adenovirus group, 41 different species have been 
identified to date. However, in contrast to the 41 HPV types, the 
different members of each subgenus show a Large degree of nucleic 
acid homology <Part I, Table 1>. Therefore DNA probes from Ad12 
and Ad31 <subgenus A), Ad7 <subgenus 8), and AdS <subgenus C) were 
used in this work as representative adenovirus probes for their 
resp~ctive subgenera, and were tested at high stringency in DNA 
dot blot and Southern blot hy~ridization tests. The HTLV-I 
specific DNA probe was also tested by dot blot hybridization at 
high stringency .. 
3.3.2 Human Papillomavirus 
3.3.2.1 Dot blot analysis 
Cellular DNA, from tumor cell Lines HCU18, HCU33 and HCU39, was 
screened by dot blot hybridization <at high stringency> to each of 
10 HPV specific probes <Table 5>. The viral DNA inserts, excised 
from their respective 
high specific activity, 
r~combinant plasmids, were Labelled to a 
in the range of <S-15) x 107 dpm/~~ DNA. 
Dilutions of cellular DNA in the range 0.5 to 4.0 ~~. were tested. 
Three negative controls were also included. These were cellular 
DNA from two Laboratory cell Lines, HeLa and HF1/81 <a human 
embryo fibroblast cell strain), and human placental DNA or foetal 
liver DNA. For HPV18, HeLa represented a positive control since 
this cell line contains HPV18 integrated into the cellular genome 
at 10-50 copies per cell <Schwarz et al., 1985>. The recombinant 
plasmid, encoding the particular viral insert used as a 
radiolabelled probe, was spotted onto the membrane <in the range 
10-80pg> as a positive control in each case. 
Results obtained for each of the 10 HPV probes. after exposure to 
X-ray f i L m for 1 0-1 4 days , are i L Lustra ted i n F i g u r e ,i2A , B and C . 
-·r,;./ 
These results clearly indicate the absence of human papillomavirus 
DNA, specifically of types 1,5,6,8,11,16 and 18, from the cellular. 
DNA of the 3 tumor cell Lines HCU18, HCU33 and HCU39. 
Weak signals were evident in certain Lanes for HPVS and HPV1, but 
since these were significantly weaker than the respective plasmid 
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FIGURE 22 
Autoradiographs of dot blot hybridization tests for the presence 
of HPV DNA in tumor and control DNA samples. Figures 22A-C show 
results obtained for HPV1CA>, the genital HPV"s, HPV 6, 11, 16 and 
18(8), and EV-asso~iated HPV5 and 8CC). Specific viral DNA probes 
<described in Section 3.2.2> are indicated alongside each figure. 
Serial twofold dilutions of the following human DNA samples, 
starti~g with 4~~. are represented in rows A-D: human fibroblast, 
strain 1/81, CHF), foetal Liver (F), human placenta CP), HeLa (H), 
and HCU18, HCU33 and HCU39 <18, 33, 39). A maximum of 80pg, and 
serial twofold dilutions Crows A-D) of the respective homologous 
HPV plasmids Cp) are represented in Lanes 7 and 8, as indicated. 
Heterologous HPV8 plasmid DNA (8/3 or 8/4) is similarly repre-
sent~d in L~nes 7 and 8 of Figures 22C-8/4 or 5/48. Lanes that 
were Left open are indicated by/. 
Ea~h of the probes was Labelled to a specific activity of <5-15) x 
10 dpm/~~ DNA. Exposure to X-ray film <Kodak XOmat MA) was for 
10-14 days. 
, I 
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controls, and did not show a clear dilution in the signal from 4 
to 0.5~~. they were interpreted as non-specific background 
hybridization of the probe DNA. 
HPV8 recombinant plasmid DNA C1TI-80pg) was included in Lane 7 of 
Figure 22C-8/4 CHPV8/3) and in Lane 8 of Figure 22C-5/48 CHPV8/4). 
Positive signals shown in the Latter are thus a result of cross-
hybridization between these closely related viruses, which have 
17% of their nucleotide sequences in common <Kremsdorf et al. 
1982). 
Control HeLa DNA was strongly positive when the 2.4kb EcoRI/BamHI 
fragment of HPV18 was used as a probe <Figure 228). When the ~.2kb 
EcoRI/BamHI fragment was used the signal was significantly weaker, 
since only a small fraction of this HPV18 DNA fragment is 
integrated in the HeLa cell genome <Schwarz et al., 1985). 
3.3.2.2 Southern blot analysis 
Although the 3 tumor cell Lines HCU18, HCU33 and HCU39, were 
clearly negative for HPV18 when tested by dot blot hybridization, 
they were also tested by Southern blot hybridization to HPV18 DNA, 
but at Low stringency <T -42°) in order to detect the possible 
m 
presence of a related HPV type that would not cross-hybridize 
under conditions of high stringency. 
Cellular DNA was extracted from the 3 cell lines, and from posi-
tive and negative controls. These included the HeLa Line, the 
human embryo fibroblast strains HF1/81 and HF4/81, and human 
placenta. DNA <10~~), was digested with EcoRI and BamHI, and 
separated in a 0.8% agarose gel, as shown in Figure 23A. The 
presence of fast migrating satellite bands, derived from repeti-
tive human DNA sequences, clearly shown in the figure, are 
indicative of complete digestion by the enzyme(s). 
The DNA was subsequently transferred to Hybond-N nylon membrane, 
and probed at Low stringency <T -42°C) with linear HPV18 DNA. A 
m 
mixture of two subgenomic fragments of HPV18 DNA, the 2.4kb 
BamHI/EcoRI fragment and the 1.1 kb BamHI fragment, was used as a 
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radiolabelled probe. These complete fragments are both integrated 
in the Hela cell genome. While the smaller of the two represents a 
noncoding regulatory region of HPV18 DNA, the 2.4kb fragment 
includes open reading frames E1, E6 and E7, which are thought to 
encode HPV transfor~ing functions <Section 1.2.3.2>. Thi membran~ 
was hybridized and washed at Low stringency <T -40°C>, and exposed 
. m 
to X-ray film overnight. Strong signals were evident in each of 
the 7 DNA Lanes but distinct bands could only be detected in the 
Hela control <results not shown>. Since the background hybridiza-
tion was 
times at 
for 1-10 
especially strong, the membrane was re-washed a further 2 
higher stringency <T -25°c>. After exposure to X-ray film m . . 
days 3 bands became clearly visible in Hela DNA, but none 
were observed in Lanes 2-7, even after Longer exposure times 
<Figure 238>. The 2 HPV18 DNA fragments used as probes are indi-
cated by arrows at the respective cellular bands which they 
recognize. This result corresponds to the pattern derived by 
Schwarz et al. (1985> for the integration of HPV18 DNA into the 
Hela cell genome. 
These results cannot conclusively exclude the presen~e of HPV18-
related sequences in the tumor DNA. The background hybridization 
was particularly strong in Lanes 5-7 and HPV specific signals 
could well have been obscured in this region. A weakly homologous 
<and possibly Low copy number> sequence may initially have ~een 
masked by background hybridization, and further not detected after 
the second wash due to probe dissociation at this higher strin-
gency CTm-25°C>. This work could have been improved by including 
additional controls: standard reconstructions, representing 
various copy numbers per cell of a heterologous HPV type, would 
have facilitated the determination of detection Limits at dif-
ferent stringencies. 
A 8 
123456789 1. 2 34 5 '6 789 
<1 1-1kb 
<J 2·4 kb I 
<1 1·1 kb 
FIGURE 23 
Low stringency hybridization tests using HPV18 DNA probes. Control 
and o e sop hag e a L tumor c e L L DNA was c Lea v e·d w i t h E coR I and 8 am HI 
and subjected to electrophoresis in 0.8Y. agarose (A). The DNA was 
transferred to Hybond-N nylon membrane, and probed with a mixture 
of two HPV18 specific DNA fragments <2.4kb and 1.1kb 8amHI/EcoRI 
restriction fragments), at Low stringency <T -42°C). The membrane 
was washed initially at T -40°C, and subseq~ently at T -25°c and 
exposed to X-ray film fo~ 7 10 days (8) . The specific a~tivity of the HPV18 probe was 8 x 10 dpm/~~. Subgenomic 8amHI/EcoRI frag-
ments of HPV18 DNA used as Labelled specific probes are indicated 
by arrows at the respective cellular bands which they recognize. 
Lane 1 = ~ Hindiii digest; 2 = HF4/81; 3 =foetal Liver DNA; 4 = 
placental DNA; 5 = HCU18; 6 = HCU33; 7 = HCU39; 8 = Hela; 9 = ~ 
Hindi!! digest. 
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3.3.2.3. Conclusion 
Dot blot hybridization tests have clearly indicated that DNA from. 
the particular human papillomavirus strains tested, namely HPV1, 
HPVS, HPV6, HPV8, HPV11, HPV16 and HPV18, is not present in 
integrated, or episomal form in the cellular DNA of th~ three 
oesophageal tumor cell Lines HCU18, HCU33 and HCU39. Hybridization 
tests for Epstein-Barr virus <refer to Section 3.3.3.1) have shown 
that- a single copy per cell of integrate~ EBV DNA can be detected 
(by Southern or dot blot hybridization> at an estimated Level of 
3pg per microgram of ~ellular DNA, by using a 7.4kb viral 
probe.For the HPV assays, single copy positive control DNA was not 
available. However, under similar conditions of stringent 
hybridization, one should also detect a single copy of HPV DNA, 7-
8kb in Length, and present at 3pg/t..lQ of cellular DNA. The plasmid 
positive controls for -each of these dot blot tests have· clearly 
' demonstrated the detection of viral DNA inserts in the range of 5-
50pg. Therefore, the presence of 1 copy of HPV DNA (of 7~8kb) 
should be within the Limits of detection of this assay. However, 
the presence of a partially integrated genome cannot be excluded; 
a single copy, Less than 3kb in Length, would not be detected at 
less than 1pg per microgram of cellular DNA. 
Southern blot hybridization, at low stringency, to an HPV18 
·specific probe, has further failed t.o demonstrate the presence of 
viral DNA, either of this HPV type, or of any related HPV strain. 
Since HPV18 does exist in an integrated state in HeLa cell DNA, 
these results also indicate that the 3 oesophageal cell lines 
examined in this study are not contaminated with HeLa cells. 
3.3.3 Epstein-Barr Virus 
For the EBV series of tests positive controls were provided by 
cellular DNA extracted from two well-known Lines, Raji and 
Namalwa. Both of these lines were established from patients with 
African B-cell <Burkitt's) Lymphoma. The Raji cells contain mul-
tiple copies of the EBV genome, present Largely in the form of 
extrachromosomal episomal DNA <Anvret et al., 1984). Namalwa 
cells, however, contain a single copy of the viral DNA which 
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exists exclusively integrated within the host cell genome <Matsuo 
et al., 1984>. Human placental DNA, and DNA extracted from the 
laboratory Hela cell Lin~. were included as negative controls. 
3.3.3.1 Hybridization to EBV BamHI F and BamHI W 
restriction fragments 
3.3.3.1.1 Southern blot hybridization 
The Bamw and BamF probes were tested by hybridization to a 
Southern blot of BamHI-digested human DNA extracted from the 3 
oesophageal tumor cell Lines CHCU18, HCU33 and HCU39) and from the 
positive and negative controls described above. The different DNA 
samples (10~~), digested with BamHI, were separated by 
electrophoresis in 0.8X agarose. Forty picograms of BamHI digested. 
EBV recombinant plasmids, pBamHIF and pBamHIW were included in 
L a.n e s 1 0 a n d 11 o f t h e g e L a s add i t i on a L c on t r o L s . 
Following stringent hybridization of a Southern blot of this gel 
to.the BamF probe (Figure 24), no hybridization to the DNA of cell 
lines HCU18 (Lane 5), HCU33 <Lane 6), or HCU39 <Lane 7>, was seen. 
I n. c on t r a s t , 
and Namalwa 
strong signals were obtained from EBV-positive Raji 
cells <Lanes 2 and. 3, respectively) and from the 
plasmid BamHIF restriction fragment in lane 10. Hybridization to 
Lambda phage DNA, evident in lanes 1 and 9 is thought to be due to 
Lambda DNA contamination of the probe, which could have occurred 
in1 the process of purifying the BamF fragment from vector se-
quences, prior to radiolabelling. 
Based upon a human genome of 3 x 109 base pairs, 1 copy of EBV DNA 
per diploid genome is therefore equivalent to 25pg of EBV BamHI F 
< 7 . 4 k b ) i n 1 0 ~·.g o f c e L l u l a r D N A . s i n c e 4 0 p g o f r e c om b i n a n t p L a s m i d 
pBamHIF contains 25pg of EBV BamHI F restriction fragment, one 
should 
( 1 0~-~) 
detect this sequence at a similar Level in Namalwa DNA 
and the plasmid control. Signals shown in Lanes 3 and 10 
<Figure 24) thus correlate well with the predicted results, and 
furthermore clearly indicate that the minimum Level of detection 
that we can achieve using this system is 1 copy, or less than 1 
copy of viral DNA per cell. 
FIGURE 24 
1. 2 3 
......... 
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Autoradiograph of Southern blot hybridization tests for the 
presence of EBV <BamHI F fragment) in tumor and control DNA 
samples. Cellular DNA <10~.J.g) digested with BamHI was separated by 
electrophoresis in 0.8r. agarose. After transfer to Hybond-N nylon 
membrane, it was hybridized 7 to 1t·.J.g of radiolabelled EBV- BamF DNA 
<specific activity, 8 x 10 dpm/~~) and exposed to X-ray film for 
10 days. 
Lane 1 = ~ Hindi!! digest; 2 = Raji; 3 = Namalwa; 4 = Hela; 5 = 
HCU18; 6 = HCU33; 7 = HCU39; 8 = human placental DNA; 9 = ~ 
Hindi!! digest; 10 = 40pg of pBamHIF; digested with BamHI . The 
positions of ~ Hindi!! restriction fragments are indicated. 
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Probe DNA was subsequently removed from the membrane by stringent 
washing, as described in Section 2.9. Further stringent hybridiza-
tion of the Bamw probe again revealed no significant signal for 
any of the 3 oesophageal tumor cell Lines HCU18, HCU33 and HCU39 
<Figure 25, Lanes 5,6 and 7, respectively). Strong signals were 
obtained for Raj i <Lane 2>, Namalwa <Lane 3) and pBamHIW (Lane 11 > 
c on t r o L s . H owe v e r , t h e s e b a n d s i n L a n e s 2 an d. 3 w e r e m u c h s t r on g e r 
than those detected in Figure 24, due to the fact that the BamHIW 
restriction fragment occurs as a repeated sequence in the EBV 
genome; it is repeated 11 times in the 895-8 strain of EBV. <Baer 
et al., 1984). Strong hybridization of BamW to flanking BamHI 
fragments c <9.22kb) andY <1.84kb) was also observed in Raji DNA, 
a nd in Namalwa DNA, after a Longer exposure time. This could 
result from strain differences in this region of the EBV genome; 
the BamHI WYH and EcoRI c sequences represent two regions where 
such differences have been noted <Baer et al., 1984>. Additional 
bands evident in Lane 2 are due to incomplete digestion by the 
enzyme; one of these <indicated by an arrow), however, represents 
hybridization to the BamF probe, which was not completely removed 
in the previous washing step. 
The very faint bands apparent in Lanes 5 <- 4.2kb), for HCU18 DNA, 
and 8 <- 2.7kb), for human placental DNA, are not regarded as 
significant since they do not migrate at, or near, the 3.07kb 
position and are much weaker than any of the controls in Lanes 2, 
3 or 11. The EBV genome has been reported to exhibit a \imited 
degree of homology with human DNA, and the BamW fragment, itself a 
repetitive sequence, was shown to be homologous to an Alu repeti-
t i v e s e qu e n c e i n mamma L i a n c h r om o s om a L D N A < A r r a n d e t a L . , 
1983). These results can thus be explained in terms of the non-
specific binding of the BamW probe to HCU18 and placental DNA 
sequences. 
Hybridization 
result of 7·, 
to ;-, DNA sequences, presumably, as for BamF, a 
contamination of the probe DNA, was again detected 
- <Lanes 1 and 9). 
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FIGURE 25 
Autoradiograph of Southern blot hybridization tests for the 
presence of EBV <BamHI W fragment) in tumor and control DNA 
samples. The Southern blot, shown in Figure 24, was re-probed with 
1 ~-LQ o f r a d i o l a b e l l e d E B V - 8 a m W D N A < s p e c i f i c a c t i v i t y , 1 x 1 0 8 
dpm/~~), and exposed to X-ray film for 5 days. 
Lane 1 
HCU18; 
Hindiii 
BamHI. 
= ~ Hindiii digest; 2 = Raji; 3 = Namalwa; 4 = Hela; 5 = 
6 = HCU33; 7 = HCU39; 8 = human placental DNA; 9 = ~ 
digest; 10 = pBamHIF; 11 = 40pg of pBamHIW, digested with 
-;-, Hindiii 
BamF probe, 
size markers are shown. Hybridization to residual EBV 
in Lane 2, is indicated by an arrow. 
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3.3.3.1 . 2 Dot blot hybridization 
The tumor cells were further tested by dot blot hybridization to 
the EBV BamF probe. The detection of a single copy viral genome 
may be inhibited in this assay due to masking by surrounding 
cellular DNA. In Southern blot hybridization tests, where DNA 
fragments are separated by electrophoresis, this restriction 
• should not be as apparent. 
Figure 26 Clane2) clearly demonstrates the detection of single 
copy EBV BamHI F at a Level of 3-4pg per microgram of cellular 
DNA: the intensity of hybridization to 4~~ of ~amalwa DNA <Lane 2, 
A> is similar to that of 20pg of plasmid control (Lane 10, C>. No 
hybridization 
control DNA 
to oesophageal tumor DNA <Lanes 7-9>, or negative 
<Lanes 3-6) was observed. Thus, from this result, it 
would appear that the sensitivity of dot blot hybridization is 
co mparable to that of Southern blot hybridization <Section 
3 . 3.3.1.1> for the detection of single copy DNA in mammalian 
genomes. 
1 2 3 4 5 6 7 8 9 10 
... 'Y 'Y 'Y 'Y 'Y . 'Y 'Y 'Y 
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FIGURE 26 
Do t blot hybridization of tumor and control DNA's to an EBV BamF 
p r o be . S e r i a L t w o f o L d d i L u t i o n s o f h u m a n D N A < 4- 0 . 5 ~·~ ) a n d p B am H I F 
C80-10pg) were applied to wells A-D. 
Lane 1 = Raji; 2 = Namalwa; 3 = HPB-ALL; 4 =human fibroblast DNA 
( 4 /81); 5 = Hela; 6 = foetal liver DNA; 7 = HCU18; 8 = HCU33; 9 = 
HCU39; 10 = pBamHIF. 
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3.3.3.2 Hybridization to E8V EcoRI C restriction fragment 
Cellular DNA extracted from the 3 cell Lines, and control 
specimens, was digested to completion with EcoRI, and separated by 
electrophoresis in 0.8X agarose . A Southern blot of this gel was 
probed at high stringency with the E8V Eeoc probe, and the result, 
as shown in Figure 27, demonstrates significant hybridization of 
the probe only in Lanes 2,3 and 10, for Raji DNA, Namalwa DNA, and 
the homologous fragment of pEcoRIC <40pg). The faster migration of 
this plasmid band in Lane 10, when compared to the respective 
sequences in Raji or Namalwa DNA can be explained by the fact that 
a deletion of - 13.6kb is present in the EcoRI C fragment of E8V 
895-8, at map position 152kb (8aer et al., 1984). A very faint 
band was detected in Lane 5 <HCU18) co-migrating with the EcoRI C 
sequence of E8V 895-8 <Lane 10). This, however, was regarded as 
insignificant, 
reasons: 
and was not analyzed further, for the following 
1. Faint hybridization was only detected in 1 of the 3 cell Lines; 
the presence of this sequence is thus not Likely to play a role -
in the genesis of malignancy . 
2. No hybridization to 8amF or Bamw probes was detected <Section 
3.3.3.1), thus excluding the presence of episomal E8V DNA in 
this Line. The whole E8V genome is normally detected in trans-
formed cell Lines and tumor tissue, whether present in episomal 
or in integrated form <Dambaugh et al., 1986). 
Although the E8V EcoRI C fragment <17.17kb) is much Larger than 
the 8amHI F fragment <7.4kb), the signal shown for the Namalwa 
control 
<Figure 
is much weaker than that obtained with the 8amF probe 
24, Lane 3). This can be explained by the Lower ef-
ficiency, both in transfer and in radiolabelling, of relatively 
Large restriction enzyme fragments. <The specific activity of the 
EeoC probe was 1.0 x 107 dpm/~-'-g DNA). The strong hybridization to 
~ DNA in Lanes 1 and 9 could be a result of contaminating ~ DNA, 
and/or cosmid vector DNA sequences, in the EeoC probe. 
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FIGURE 27 
Autorad i ograph of Southern blot hybridization tests for the 
presence of EBV <EcoRI C fragment) in tumor and control DNA 
samples . Sample DNA (10t-J.g) digested wi th EcoRI, was separated by 
electrophoresis in 0.8X agarose and immobilized on Hybond-N nylon 
membrane. The membrane was probed with an EBV EeoC probe <specific 
activity 1 x 10 7 dpm/~~) and exposed to X-ray film for 14 days. 
Lane 1 = x Hindiii digest; 2 = Raji; 3 = Namalwa; 4 = Hela; 5 = 
HCU18; 6 = HCU33; 7 = HCU39; 8 = human placental DNA; 9 = ~ 
Hindiii digest; 10 = 40pg of pEcoRIC, digested with EcoRI. 
/-._ Hindiii size markers are indicated. 
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3.3.3.3 Conclusion 
These results have shown that the EBV genome is not stably in-
tegrated Cor present episomally> in the cellular DNA of the 3 
oesophageal tumor cell lines, HCU18, HCU33 and HCU39. Probes 
derived from 3 EBV restriction +ragments were tested: BamHI W and 
BamHI F include sequences represented by the pS region of the EBV 
g~nome, encoding putative a-Lymphocyte immortalizing protein(s), 
w h i l e E coR I. C i n c l u des seq u en c e s r e p r e sent e d by p 31 w h i c h i s 
immortalizing for epithelial cells (Griffin and Karran~ 1984). 
Although hybridization to the Eeoc probe was detected in line 
HCU18, the possible presence of this fragment in only 1 of the 
3 tu~or cell lines was not r•garded as significant. 
Since EBV exists as a single copy integrated in the Namalwa cell 
genome, these results ha~e further shown that the detection limit 
of our system <under conditions of high stringency hybridization) 
is 1 copy, or less than 1 copy, of viral DNA per cell. 
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3.3.4 Human adenovirus 
The 3 oesophageal tumor lines <HCU18, HCU33, HCU39> were analyzed 
by dot blot hybridization to 4 different adenovirus probes. The 
results, as shown in Figure 28A-C were interpreted as follows: 
1. Subgenus A Ad12 <EcoRI c ·probe) and Ad31 <8amHI probe) 
2 . 
demonstrated hybridization only in lanes 1 for their respec-
tive plasmid controls. 
Subgenus 8 
hybridization 
2203) diluted 
Ad7 (Hindiii J probe> showed significant 
for positive control - Ad7 viral DNA (strain 
in the range 50 400 pg - in lane 1. Weak 
signals were also apparent in lanes 2-6, for tumor and control 
DNA samples. 
3. Subgenus c : AdS <Hindlll G probe) hybridized strongly to the 
plasmid control in lane 1. Weak signals were also detected for 
HCU18 <lane 4) and HCU39 <lane 2) DNA, and for negative con-
trols <HF, HeLa> in lanes 6 and 7. 
In order to confirm the fact that the inconclusive results, as 
shown in Figures 288 and C, were negative, the 3 tumor lines were 
further tested by Southern blot hybridization to AdS and Ad7 
specific p~obes. Cellular DNA <10~~), from.the same control and 
test specimens, was digested with Sacl and transferred to Hybond-N 
nylon membrane. Hybridization to an AdS Hindiii J probe showed no 
signal for tumor and control human DNA's <Figure 28D, .lanes 2-7> 
and strong signals only in lane·1 for the plasmid pAdSXhoiC con-
trol <100pg). Similar probing of this membrane with the Ad7 
Hindiii J probe showed no hybridization, even after a 3 week 
exposure time <results not shown>. 
Since the human adenoviruses have been reported to exhibit some 
homologj to human DNA <Arrand et al., 1983), the weak signals 
observed in Figures 288 and C are accepted to represent non-
specific hybridizatipn of the AdS and Ad7 DNA sequences. Arrand et 
~ <1983) have demonstrated that specific regions of the 
adenovirus genome. have close homology to human DNA sequences. It 
is of interest that subgenus 8 and C, but not subgenus A, members 
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exhibited such homology within their respective transforming 
regions. 
Ad12 Ad31 
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FIGURE 28 
Autoradiographs of dot blot <A-C) and Southern blot <D) hybridiza-
~ion tests for the presence of adenovirus DNA in tumor and control 
DNA samples . Prob~s from Ad12 and Ad31, of subgenus A (A), Ad7 of 
subgenus 8 (8) and AdS of subgenus c <c and D) were used, as 
described in the text. Serial twofold dilutions <4-0.5~~) of the 
following human DNA samples are represented in rows A-D: HCU39 
(Lanes 2), HCU33 <Lanes 3), HCU18 <Lanes 4) human placental DNA 
<Lanes 5), Hela <Lanes 6), HF 4/81 <Lanes 7). 
A maximum of 80pg and serial twofold dilutions <rows A-D) of 
recombinant plasmid DNA's are represented in Lanes 1 of F i gures 
28A and C. Similar dilutions of Ad7 DNA <strain 2203), in the 
r a n g e 5 0- 4 0 0 p g a r ·e r e p r e s e n t e d i n L a n e 1 o f F i g u r e 2 8 8 . S a c I 
digested pAdSXhoiC DNA <100pg) is shown in Lane 1 of Figure 28D, 
as a positive control. 
Probes were Labelled to a specific activity of <5-10) x 10 7 dpm/ ~~ 
DNA. Exposure to X-ray film was for 10-14 days . 
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3.3.4.1 Conclusion 
The 3 oesophageal cell Lines <HCU18, HCU33, HCU39) were screened 
for transforming DNA sequences from Ad12 and Ad31 of highly 
oncogenic subgenus A, Ad7 of weakly oncogenic subgenus B and AdS 
of nononcogenic subgenus C. The results as shown failed to 
demonstrate the presence of viral DNA within these cells. 
Human adenov .iruses within each subgenus have homologous transform-
ing regions, specific to that subgenus <Green et al . , 1979). 
Therefore hybridization studies using a given strain are ap-
plicable to other strains within the same subgenus. Based on a 
human genome of 3 x 109 base pairs, one should detect the presence 
of 1 copy of adenovirus DNA per cell at an approximate Level of 
2pg/ ~~ cellular DNA, using a 5-6 kb probe. Thus, according to the 
same criteria discussed in Section 3.3.2.3, this system should 
detect members of subgenera A and C at such a Level, and the 
negative results shown for Ad12, Ad31 and AdS can be interpreted 
to exclude the presence 
three tumor cell Lines. 
of members of subgenera A and c in the 
Although the 1 .34kb Ad7 probe may not 
detect the presence of one copy of viral DNA per cell, Southern 
blot hybridization to this probe was clearly negative, after Long 
exposure to sensitive X-ray film <Kodak XOmat AR5). Furthermore, 
\ 
most adenovirus transformed cells have been found to contain 
multiple copies of the Left-hand transforming region of the virus 
<Fujinaga et al., 1984). Therefore, in addition to groups A and C, 
we can, with some certainty, exclude a group a-adenovirus involve-
ment in the oesophageal tumor cells. 
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3.3.5 Human T-Lymphotropic Virus Type-! 
Cellular DNA from tumor Lines HCU18, HCU33 and HCU39 was shown to 
be negative when screened for the presence of integrated HTLV-I 
DNA: A dot blot probed with the HTLV-I specific DNA probe is shown 
in Figure 29. The two positive controls, plasmid pMT2 DNA <Lane 1) 
and DNA from the HTLV-I producer Line, C91/PL <Lane 7), are 
strongly positive. However, oesophageal tumor DNA <Lanes 2-4) and 
negative control DNA <Lanes 5 and 6) are clearly negative for the 
presence of HTLV-I. 
A 
B 
c 
D 
FIGURE 29 
3 
• 
4 
• 
5 
• 
7 
• 
Dot blot hybridization of tumor and control DNA's to an HTLV-I DNA 
probe. Serial twofold dilutions of human DNA <4-0 . 5~~) ard plasmid 
pMT2 <80-10pg) were applied to wells A-D. 
Lane 1 = pMT2; 2 = HCU39; 3 = HCU33; 4 = HCU18; 5 = human placen-
tal DNA; 6 = HF 4/81; 7 = C91/PL. 
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4. DISCUSSION 
The aetiology of oesophageal cancer is at present the subiett df 
intense investigation. There are two major unexplained-observa-
tions relating to this neoplasm: 
1. the striking regional variation in the incidence of the 
disease; and 
2. the sharp rise in the incidence in South Africa in the Last 
25 years. 
Both of these observations can be explained, although not ex-
clusively, on the basis ot a viral aetiology. While there is very 
Little direct evidence to support such an aetiology, there have 
been several reports describing morphological changes indicative 
of papillomavirus infection of the oesophagus CSyrjanen: et al., 
1982.; Winkler et al., 1985; Hille et al., 1985; Hille et al., 
1986). In these studies, infected epithelia were identified close 
to, or adja~ent to, invasive squamous carcinomas. HPV antigens 
have also been demonstrated in certain of the specimens showing 
such morphological changes <Hille et al., 1986; Winkler et al., 
1985). A number of workers have consequently proposed that, in 
analogy to cervical carcinoma, HPV may be involved in the develop-
ment of squamous carcinoma of the oesophagus. 
The presence of an oncogenic 
communities could expl.ain why 
incidence occur. In addition 
HPV subtype in certain Localized 
striking 
to the 
differences in cancer 
escalating incidence of 
oesophageal carcinoma, the incidence of HPV infections in the 
btack population of South Africa has also reached epidemic propor-
tions <Morris and Price~ 1986). The close-Living conditions found 
in certain isolated communities, and those that are also prone to 
malnutrition, would favour the spread of virus. The disease is 
reported to be particulaii~ common in communities where malnutri-
-~ 
tion is Likely to be found <Section 1.1 .1). It is of interest that 
carcinoma of the mouth, pharynx and bronchus have been found to be 
associated with oesophageal cancer <Fitzpatrick etal., 1985). 
Furthermore, a high incidence of HPV-induced Lesions of the oral 
cavity has been reported in close-Living, isolated communities in 
South Africa (VanWyk, 1977). 
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Evidence ,for the possible role of a viral factor in the aetiology 
of oesphageal carcinoma is perhaps best provided by the demonstra-
tion of viral particles in the tumor cells. While histology and 
immunoperoxidase methods alone are not entirely conclusive of a 
viral infection, absolute confirmation could be provided by 
electron microscopy and molecular hybridization techniques, Three 
oesophageal carcinoma cell lines, HCU18, HCU33, and HCU39, were 
examined in this study by transmission electron microscopy. While 
several morphological features suggestive of a possible viral 
activity were noted, the reported absence <Robinson,· 1981> of 
virus particles from these cells was confirmed in this study. 
In general, cellular transformation by DNA and RNA viruses is 
accompanied by integration of viral sequences required for the 
' maintenance of transformatioo. Although the HPV's were originally 
believed to be an exception to this rule <Pfister, 1984> recent 
studies have demonstrated the integration of HPV18 and HPV16 DNA 
in genital carcinomas (Schwarz ~tal., 1985; Choo et al., 1987; 
Pater et al., 1986; Durst et al., 1983, 1985>. These two HPV types 
are mainly f6und in an integrated form {n· carcinoma tissue, and 
cell Lines derived from such tissue, but in an episomal form in 
benign tumors. It has been postulated that integration into the 
host genome occurs during transition from a noninvasive to an 
invasive stage of tumorigenesis <Pater et al., 1986>. Such an 
~vent may thus be important in the induction and/or the main-
tenance of malignancy, and may also pertain ~o other squamous cell 
carcinomas such as oesophageal carcinoma. DNA hybridization tests, 
described in the present· study have, however, shown that human 
papillomavirus <types 1,5,6,8,11,16 and 18> are not present in the 
cellular DNA of the 3 oes6phageal cell Lines HCU18, 33 and 39. 
Similar negative results were demonstrated for Epstein-Barr virus, 
human adenoviruses (species 12,31,7 and 5> and HTLV-I. These 
results indicate, at Least for the particular virus types tested, 
that stable integration of the viral genome is not essential for 
the maintenance of the malignant phenotype. 
The HPV probes that were used included the putative oncogenic 
types 5,8,16 and 18, as well as HPV6 and 11, frequently identified 
in carcinomas of the Larynx and the oral cavity. Results obtained 
with these specific probes cannot exclude the possible involvement 
of HPV in the 3 cell lines. The number of identified virus types 
) 
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is steadily increasing at the momeht; 41 types 
have been iden-
tified to date and this is almost twice the number 
that were known 
2 years ago. These different types are remarkaQly heterogene
ous, 
and all show less than 50~ cross-hybridization.
 It is possible 
that HPV DNA, from a type not yet identified, 
is present in an 
integrated form in the oesophageal tumor cell
s. However, low 
stringency hybridization <Tm-42°C>, with an HPV18 
probe failed to 
detect the presence of viral DNA in these cells. 
All 41 HPV types 
identified to date have been shown to cross-
hybridize under 
relaxed conditions of hybridization <Kahn et 
al., 1~86), and 
Ostrow et al. <1987) have recently demonstrated that under t
hese 
conditions 'heterologous' types can be detected at 
a Level of less 
than 1 copy per diploid cell. It therefore seem
s unlikely that 
_viral DNA from any of the 36 HPV types that we
re not tested is 
present within these cella. Furthermore, these 
negative resul~s 
were recently confirmed by those of de Villiers and
 coworkers, who 
have analyzed 10 of the South African oesophagea
l carcinoma cell 
lines (including about 35 biopsy specimens) a_t varying st
rin-
gencies, and with a variety of different HPV prob
es <de Villiers, 
1986, personal communication). 
The adenovirus and EBV probes that were used in 
this study were 
all derived from transforming regions of ·these 
viruses. For the 
.human adenoviruses this E1 region is well-define
d and homologous 
for different members of each subgenus <Green et a
l., 1979). Since 
the integration and expression of E1 seque~ces 
is essential for 
the oncogenicity of adenoviruses, the ne
gative results 
demonstrated for these viruses indicate that su
bgenus A, B or c 
members are'not involved in the 3 oe~ophageal tumor lin
es. 
In contrast to the adenovirus E1 region, t~e tran
sforming region 
of EBV has not been well defined. Protein produ
cts encoded by 4 
different regions of the viral genome <LT1 ~ LT4) have been im
pli-
cated in EBV induced a-lymphocyte transform
ation (Section 
1.2.2.3>. The expression of LT1 <encoded by BamHI
W sequences) is 
specifically regarded as essential for transfo
rmation by this 
virus (Kieft et al., 1982). However, recent studies bi Rowe et al. 
<1986) have revealed that the 2 protein products encoded by
 LT3 
and LT1 are not expressed in certain newly estab
lished EBV con-
taining BL cell lines. This suggests that n
either of these· 
products is required for continuous growth of EBV
-positive BL cell 
\ 
111 
the EBV genome, not represented by the three probes used in this 
study <Bamw, BamF and EeoC>, could encode such functions and exist 
in an integrated form in the 3 tumor Lines. However, this is 
unlikely in view of the fact that in most BL derived cell Lines 
EBV exists in an episomal state, and furthermore the entire viral 
genome is always present.even when it is integrated~ as in Namalwa 
DNA <Matsuo et al., 1984>. 
The absence of integrated <or episomal) viral DNA from cell Li~es 
HCU18, HCU33 and HCU39 may be interpreted in several ways: 
1. Carcinomas generally consist of a mixture of heterogeneous 
cells. The oesophageal tumor Lines tested in this survey may 
thus not be representative'of the cells initially transformed 
in vivo. However, extensive in vivo and in vitro studies have 
indicated that several properties of these, and other 
oesophageal carcinoma cell Lines <initiated during the same 
period), correlate well with those of the source tumors in 
vivo: Lines developed from poorly differentiated tumors showed 
similarities to one another, as did those from well differen-
tiated tumors <Robinson, 1981>. 
2 . The oesophageal tumor cells in this survey have been exten-
and the fact that cells may become altered, sively 
both 
passaged, 
in genotype and in phenotype, during adaptation to an in 
vitro environment must be.considered. Since the cells would be 
subject to different genetic constraints, depending on their 
environment, the expression of specific viral proteins in 
these cells may be essential for the maintenance of malignancy 
in vivo, but not required for malignant growth in vitro. It is 
thus conceivable that the presence of the viral genome is no 
longer required, even if persistence of the virus was neces-
sary for the initial proliferation <and/or maintenance> of 
tumor cells in vivo. 
3. A "hit and run" mechanism, similar to that suggested for 
herpes simpl~x virus <Galloway et al., 1984) may pertain to 
the oesophageal carcinomas currently under investigation. In 
terms of this mechanism, transient infection of the host cell 
is sufficient to mutate or, diregulate crucial transcriptional 
units and to initiate transformation;.continuous presence of 
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viral DNA is, however, not required to maintain the malignant 
phenotype (Campo et al., 1985>. In support of such a model, 
Jarrett et al. (1986, personal communication) have recently 
demonstrated that transformed cells from bovine 
papillomavirus-induced papillomas, can be cultured and shown 
to induce tumors in nude mice. However, these cells, which 
can only be grown out in the very early stages of tumor induc-
tion, do not contain papillomavirus genome, either episomally 
or integrated. While it is thought that such a mechanism might 
also apply .to human viruses, the nature of this whit and runw 
effect remains unknown. 
In conclusion, it is clear that more extensive studies, par-
ticularly using fresh tumor material, need to be carried out in 
order to further elucidate the possible role of a viral co-factor 
in the aetiology of oesophageal carcinoma. 
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APPENDIX I - MATERIALS 
1 . 1 TISSUE CULTURE 
1 . 1 . 1 Miscellaneous Solutions 
(a) Physiological sal~ne 
0.85% Cw/v) NaCl in distilled H20. 
(b) Trypan blue 
0.5% Cw/v) trypan blue in physiological saline. 
Filter through paper prior to use. 
Cc> PSN solution· 
To make 100 ml: 
6 
Dissolve 2 x 10 units penicillin <2 bottles>, 2g strep-
tomycin <2 bottles), 2g neomycin <4 bottles), in 100 ml 
physiological saline. 
Filter sterilize, dispense into 3ml aliquots, and store at 
-2o 0 c. 
<d> Phenol red <0.4%> 
To make 100ml: 
Dissolve 0.4g phenol red in 60ml SOmM NaOH, and make up to 
100ml with distilled H2o. 
Sterilize by filtration. 
Ce) 5% sodium bicarbonate solution 
5% Cw/v) NaHc0 3 , 0.1% Cv/~) phenol red solution <0.4%) in 
distilled H20. co 2 is bubbled through the solution; it is 
then filter sterilized, dispensed in bijou bottles 
0 
<Leaving no air space), and stored at 4 C. 
\ 
' 
\ 
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1 . 1 . 2 Cell culture media 
<<3> 10% MEM 
Eagle's minimum essential medium <MEM) <Gibco Europe), with 
Earle's salts. L-Glutamine and non-essential amino acid~. was used 
as a growth medium. It was supplemented with 10% (v/v) foetal calf 
serum <state Vaccine Institute, ·south Africa>, 1% <vlv) ~odium 
bicarbonate solution, and 0.5% <vlv> PSN solution. The.pH was 
maintained at approximately 7.0. Foetal calf serum was sterilized 
by filtration and UV irradiation, and heat-inactivated at 56°C for 
30 mins. 
{b) 4% MEM 
Eagle's MEM, with Earle's salts, L-Glutamine and non-essential 
amino acids, was used· as a maintenance medium. It was supplemented 
with 4% <vlv> foetal calf serum, 2% <vlv> sodium bicarbonate 
solution, and 0.5% (v/v) PSN solution. 
(c) 10% RPMI 
RPM! 1640 medium <Gibco Europe), with L-Glutamine· was used as a 
g r ow t h m e d i u m· f o r t h e R a j i c e l l l i n e . I t w a s s up p l e me n t e d w i t h 1 0% 
Cv/v) foetal calf serum, 1% <v/v) sodium bicarbonate solution, and 
0.5% <vlv> PSN solution. 
Cell culture media were sterilized by filtration prior to use. 
1 . 1 . 3 Buffers 
(a) Phosphate buffered saline <PBS> 
NaCl 
KCl 
Na 2HP0 4 .. 
KH 2Po4 ... 
8g 
0.2g' 
0.91g 
0.12g 
in 1 litre of distilled H20. 
Adjust the pH to 7.0 with HCl or NaOH; sterilize by 
autoclaving <115°C; 20 min). 
·' 
<b> Hepes buffer 
To make 100 ml of 1M stock solution: 
Dissolve 23.8g Hepes in 80 ml of 0.3N NaOH. 
Adjust the pH to 7.2 <with 1N NaOH or 1N HCL). 
Make up to 100ml with distille~ H2o. 
Sterilize by filtration. 
(c) Freezing medium 
100ml of 10~ MEM containing 0.5X (v/v) PSN solution, 
7.5% Cv/v) dimethylsulphoxide CDMSO) and 1.5~ Cv/v) 
Hepes buffer. 
<d> Trypsin base 
To make 1 Litre of a 10X stock solution: 
NaCL 80~0g· 
KCL 2.0g 
KH 2Po 4 1.2g 
Na 2HP0 4 <anhydrous> 9.1g 
Phenol Red (0.4%) 25.0ml 
Glucose .. 5.0g 
Dissolve in about ·700ml of distilled H20. and adjust to 
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;c 
' 
pH7.8: ~ 
Add 2g EDTA in 100mL·distilled H20, and adjust to pH7.8 
With 1N NaOH. 
·Make up to 1000ml with distilled H20. 
0 Filter· sterilize, and store at -20 c in ~0 ml aliquots. 
<e> Trypsin 
5~ trypsin stock .solution: 
Acidify 100ml of trypsin base C1X in distilled H20> 
to bright yellow with 1N HCL. 
Dissolve trypsin powder in 1X trypsin base without 
agitation, at room temperature. 
Incubate at 4°C overnight. 
Stir for 30 mins at room temperature. 
Centrifuge at 9000 rpm for 45 mins C4°C; Sorvall RC-5 
centrifuge>. 
· · ·1 ~ 25ml 
. ' I 
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APPENDIX II - TISSUE CULTURE METHODS 
2.1 Recovery of Cells from Ampoules Stored in Liquid Nitrogen 
Ampoules, containing the cells, were removed from storage in 
liquid nitrogen 0 and placed in· a beaker of water at 37 C, to thaw 
the contents rapidly and thus reduce cell damage. The cell suspen-
sion was diluted 8-10 fold with 10% MEM, or with 10% RPMI in the 
case of Raji cells. Cells were then pelleted, in a bench-top 
centrifuge at 1500 rpm for 5 mins, washed with sterile, 
physiological saline to remove any remaining DMSO, and resuspended 
in 10ml of 10r. MEM <or RPMI, for Raji cells). After counting the 
cells <Section 2.4), they were seeded, in the appropriate culture 
medium, at a concentration of 1 x 10 5 cells/ml. This seeding rate 
was applicable to HCU18, HCU33, HCU39, Hela and Raji cell Lines. 
5 
Human fibroblast cells were seeded at a concentration of 2 x 10 
cells/ml. 
2.2 Passage of Cells 
Cell cultures were passaged when monolayers reached confluence, 
usually once or twice per week for oesophageal tumor cell lines. 
The growth medium was discarded, and cell sheets were rinsed with 
4-5ml of sterile physiological saline to remove any remaining 
medium. A thin layer of activated trypsin versene CATV), prewarmed 
to 37°C, was pipetted over the surface of the cells. After incuba-
tion at 37°c for 15 mins, cells were dislodg~d from the growth 
surface, and a small volume of culture medium was added in order 
to inactivate the trypsin. The resultant suspension of cells was 
pelleted <1500 rpm for· 5 mins), resuspended in 10ml of culture 
medium <10% MEM) and counted <Section 2.4). Cells were then 
diluted and seeded at appropriate concentrations. After 24 hours, 
when monolayers were established, the culture medium was replaced 
with fresh 10r. MEM. Alternatively, if rapid cell growth was not 
required, a maintenance medium, or MEM supplemented with 4Y. foetal 
calf serum, (4% MEM) was used. 
Raji cells are grown in suspension in 10r. RPM1 medium. Cells were 
therefore separated from the culture medium by centrifugation 
<1500 rpm for 5-10 mins>, resuspended, and seeded as described 
above. 
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ALL cell Lines, apart from Hela, were incubated in a co 2 incubator 
at 37°C. The bicarbonate in the culture medium was thus made up to 
a final concentration of 0.25%, in order to maintain t~e pH at a 
Level of pH6-pH7. 
2.3 Storage of Oesophageal Tumor Cells (HCU18, HCU33, HCU39) 
in Liquid Nitrogen at -180°C 
The cell culture medium was removed and confluent cell monolayers 
we r e w a•s h e d w i t h 4- 5 m l of s t e r i l e ph y s i o log i c a L s a l i n e , and h a r-
vested 
1500 rpm 
ATV. 
mins, 
The resultant cell suspension was pelleted at 
and then resuspended in 2ml of storage buffer 
<per 
final 
75. 
using 
for 5 
2 
em flask). Cells were diluted in storage buffer to a 
6 
concentration of <1-2)x10 cells/ml, and dispensed into 
ampoules containing 1ml each. Ampoules were frozen in a controlled 
rate freezing machine to minimize cell damage. They were then 
stored in Liquid nitrogen at -180°C. 
2.4 Determination of Cell Concentration 
Cells were counted using a haemocytometer <Bausch and Lamb), as 
follows: 
The cell suspension to be counted was made up to a volume of 10ml 
with culture medium. A 0.1ml aliquot of the suspension was diluted 
with an equal volume of trypan blue solution, and applied to the 
graduated section of a haemocytometer such that the surface was 
j us t covered . By· v i e w i n g under the m i c r o scope < W i L d He e r b rug g) the 
average cell count per square, 0.001mm 3 in volume, in a total of 
four squares, was determined. The cell concentration could then be 
calculated: 
Cell concentration = Total No. of cells x 2 x_ 10 4 cells/ml 4 
To determine the total cell count, this value was multiplied by 
the total volume of cell suspension. 
2.5 Growth of Cells on Coverslips and in Roller Tubes 
Cells that were to be stained for light microscopy were grown on 
glass coverslips, lying free within airtight, sterile, glass 
roller tubes <Kimax). Human fibroblasts <HF) cells, which will not 
\. 
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grow on glass surfaces,. were cultured on the walls of airtight, 
sterile, plastic roller tubes <Falcon>. Infection of these HF 
cells with various adenovirus isolates was used for the initial 
identification ·of laboratory Ad. 
purpose of virus propagation. 
strains, ·as well as for the 
Cells grown in tissue culture flasks were detached by trypsiniza-
tion, resuspended in fresh 10% MEM, and then diluted to a final 
concentration of <2-4> x 10 5 cells/ml. Aliquots <1ml> of this 
suspension were pipetted into airtight, sterile roller ·tubes. 
These tubes were incubated, at an angle, in a 37°C incubator for 
24 hours. After this time the culture medium was removed and 
replaced with 2ml of 4% MEM. Incubation was continued, rolling the 
tubes, until cell monolayers were confluent~ or in the case of 
infected cell cultures, until a visible cytopathic change was 
evident. The movement reduces the amount of debris that settles on 
the culture, resulting in a clearer evaluation of cytopathology. 
Coverslip culture~ could then be removed, stained with 
haematoxylin and eosin according to standard procedure <Humason, 
1972>, and mounted on glass slides for viewing under a light 
microscope (Wild He~rbrugg>. 
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